1
|
Johnson L, Newman-Norlund R, Teghipco A, Rorden C, Bonilha L, Fridriksson J. Progressive lesion necrosis is related to increasing aphasia severity in chronic stroke. Neuroimage Clin 2024; 41:103566. [PMID: 38280310 PMCID: PMC10835598 DOI: 10.1016/j.nicl.2024.103566] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2023] [Revised: 01/08/2024] [Accepted: 01/08/2024] [Indexed: 01/29/2024]
Abstract
BACKGROUND Volumetric investigations of cortical damage resulting from stroke indicate that lesion size and shape continue to change even in the chronic stage of recovery. However, the potential clinical relevance of continued lesion growth has yet to be examined. In the present study, we investigated the prevalence of lesion expansion and the relationship between expansion and changes in aphasia severity in a large sample of individuals in the chronic stage of aphasia recovery. METHODS Retrospective structural MRI scans from 104 S survivors with at least 2 observations (k = 301 observations; mean time between scans = 31 months) were included. Lesion demarcation was performed using an automated lesion segmentation software and lesion volumes at each timepoint were subsequently calculated. A linear mixed effects model was conducted to investigate the effect of days between scan on lesion expansion. Finally, we investigated the association between lesion expansion and changes on the Western Aphasia Battery (WAB) in a group of participants assessed and scanned at 2 timepoints (N = 54) using a GLM. RESULTS Most participants (81 %) showed evidence of lesion expansion. The mixed effects model revealed lesion volumes significantly increase, on average, by 0.02 cc each day (7.3 cc per year) following a scan (p < 0.0001). Change on language performance was significantly associated with change in lesion volume (p = 0.025) and age at stroke (p = 0.031). The results suggest that with every 10 cc increase in lesion size, language performance decreases by 0.9 points, and for every 10-year increase in age at stroke, language performance decreases by 1.9 points. CONCLUSIONS The present study confirms and extends prior reports that lesion expansion occurs well into the chronic stage of stroke. For the first time, we present evidence that expansion is predictive of longitudinal changes in language performance in individuals with aphasia. Future research should focus on the potential mechanisms that may lead to necrosis in areas surrounding the chronic stroke lesion.
Collapse
|
2
|
Izawa J, Higo N, Murata Y. Accounting for the valley of recovery during post-stroke rehabilitation training via a model-based analysis of macaque manual dexterity. FRONTIERS IN REHABILITATION SCIENCES 2022; 3:1042912. [PMID: 36644290 PMCID: PMC9838193 DOI: 10.3389/fresc.2022.1042912] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 09/24/2022] [Accepted: 12/01/2022] [Indexed: 12/24/2022]
Abstract
Background True recovery, in which a stroke patient regains the same precise motor skills observed in prestroke conditions, is the fundamental goal of rehabilitation training. However, a transient drop in task performance during rehabilitation training after stroke, observed in human clinical outcome as well as in both macaque and squirrel monkey retrieval data, might prevent smooth transitions during recovery. This drop, i.e., recovery valley, often occurs during the transition from compensatory skill to precision skill. Here, we sought computational mechanisms behind such transitions and recovery. Analogous to motor skill learning, we considered that the motor recovery process is composed of spontaneous recovery and training-induced recovery. Specifically, we hypothesized that the interaction of these multiple skill update processes might determine profiles of the recovery valley. Methods A computational model of motor recovery was developed based on a state-space model of motor learning that incorporates a retention factor and interaction terms for training-induced recovery and spontaneous recovery. The model was fit to previously reported macaque motor recovery data where the monkey practiced precision grip skills after a lesion in the sensorimotor area in the cortex. Multiple computational models and the effects of each parameter were examined by model comparisons based on information criteria and sensitivity analyses of each parameter. Result Both training-induced and spontaneous recoveries were necessary to explain the behavioral data. Since these two factors contributed following logarithmic function, the training-induced recovery were effective only after spontaneous biological recovery had developed. In the training-induced recovery component, the practice of the compensation also contributed to recovery of the precision grip skill as if there is a significant generalization effect of learning between these two skills. In addition, a retention factor was critical to explain the recovery profiles. Conclusions We found that spontaneous recovery, training-induced recovery, retention factors, and interaction terms are crucial to explain recovery and recovery valley profiles. This simulation-based examination of the model parameters provides suggestions for effective rehabilitation methods to prevent the recovery valley, such as plasticity-promoting medications, brain stimulation, and robotic rehabilitation technologies.
Collapse
Affiliation(s)
- Jun Izawa
- Faculty of Engineering, Information and Systems, University of Tsukuba, Tsukuba, Japan,Correspondence: Jun Izawa Yumi Murata
| | - Noriyuki Higo
- Neurorehabilitation Research Group, Human Informatics and Interaction Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Japan
| | - Yumi Murata
- Neurorehabilitation Research Group, Human Informatics and Interaction Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Japan,Correspondence: Jun Izawa Yumi Murata
| |
Collapse
|
3
|
Fang S, Weng S, Li L, Guo Y, Fan X, Zhang Z, Jiang T, Wang Y. Association of homotopic areas in the right hemisphere with language deficits in the short term after tumor resection. J Neurosurg 2022; 138:1206-1215. [PMID: 36308477 DOI: 10.3171/2022.9.jns221475] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2022] [Accepted: 09/08/2022] [Indexed: 11/06/2022]
Abstract
OBJECTIVE
It is important to identify language deficit and recovery in the week following a tumor resection procedure. The homotopic Broca’s area and the superior longitudinal fasciculus in the right hemisphere participate in language functional compensation. However, the nodes in these structures, as well as their contributions to language rehabilitation, remain unknown. In this study, the authors investigated the association of homotopic areas in the right hemisphere with language deficit.
METHODS
The authors retrospectively reviewed the records of 50 right-handed patients with left hemispheric lower-grade glioma that had been surgically treated between June 2020 and May 2022. The patients were divided into normal and aphasia groups based on their postoperative aphasia quotient (AQ) from the Western Aphasia Battery. Preoperative (within 24 hours before surgery) and postoperative (7 days after tumor resection) diffusion tensor images were used to reveal alterations of structural networks by using graphic theory analysis. The shortest distance between the glioma and the nodes belonging to the language network (SDTN) was quantitatively assessed. Pearson’s correlation and causal mediation analyses were used to identify correlations and mediator factors among SDTN, topological properties, and AQs.
RESULTS
Postoperative nodal local efficiency of the node dorsal Brodmann area (BA) 44 (A44d; p = 0.0330), nodal clustering coefficient of the nodes A44d (p = 0.0402) and dorsal lateral BA6 (A6dl; p = 0.0097), and nodal degree centrality (p = 0.0058) of the node medial BA7 (A7m) were higher in the normal group than in the aphasia group. SDTN was positively correlated with postoperative AQ (r = 0.457, p = 0.0009) and ΔAQ (r = 0.588, p < 0.0001). The nodal local efficiency of node A44d and the nodal efficiency, nodal betweenness centrality, and degree centrality of node A7m were mediators of SDTN and postoperative AQs.
CONCLUSIONS
The decreased ability of nodes A44d, A6dl, and A7m to convey information in the right hemisphere was associated with short-term language deficits after tumor resection. A smaller SDTN induced a worsened postoperative language deficit through a significant decrease in the ability to convey information from these three nodes.
Collapse
Affiliation(s)
- Shengyu Fang
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing
- Beijing Neurosurgical Institute, Capital Medical University, Beijing; and
| | - Shimeng Weng
- Beijing Neurosurgical Institute, Capital Medical University, Beijing; and
| | - Lianwang Li
- Beijing Neurosurgical Institute, Capital Medical University, Beijing; and
| | - Yuhao Guo
- Beijing Neurosurgical Institute, Capital Medical University, Beijing; and
| | - Xing Fan
- Beijing Neurosurgical Institute, Capital Medical University, Beijing; and
| | - Zhong Zhang
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing
| | - Tao Jiang
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing
- Research Unit of Accurate Diagnosis, Treatment, and Translational Medicine of Brain Tumors, Chinese Academy of Medical Sciences, Beijing, China
| | - Yinyan Wang
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing
| |
Collapse
|
4
|
Tang X, Yu Q, Guo M, Liu F, Pan Y, Zhou J, Zou Y, Wu C, Yu K, Fan M, Sun L. Multi-modal fMRI and TMS follow-up study of motor cortical stroke caused by hyaluronic acid filler: A case report. Front Neurol 2022; 13:903648. [PMID: 36158945 PMCID: PMC9492836 DOI: 10.3389/fneur.2022.903648] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2022] [Accepted: 08/15/2022] [Indexed: 11/13/2022] Open
Abstract
Background Blindness and stroke resulting from hyaluronic acid (HA) fillers are not frequently reported complications. Reports on stroke recovery after HA injection are limited. In the current study, the recovery process, task-based functional magnetic resonance imaging (fMRI), diffusion tensor imaging (DTI), and neurophysiological changes of a patient with monocular blindness and ipsilateral motor cortical stroke after forehead injection of HA are explored. Case-report The study comprised a 34-year-old female patient who presented with left eye blindness and a stroke after receiving an HA injection a month before admission. The lesion was mainly limited to the left precentral gyrus, and the patient had pure arm monoparesis. For 3 weeks, the patient received conventional rehabilitation treatments and ten sessions of repetitive transcranial magnetic stimulation (rTMS) intervention. Clinical assessments, neurophysiological evaluation, task-based fMRI, and DTI examinations were conducted to assess her motor improvement and the possible neuro mechanism. Clinical rehabilitation impact The patient's right upper limb motor function was almost completely restored after receiving rehabilitation therapy. However, the vision in her left eye did not show significant improvement. The neurophysiological evaluation showed partial recovery of the ipsilesional motor evoked potentials (MEPs). DTI results showed that the ipsilesional corticospinal tract (CST) was intact. Task-based fMRI results indicated that the activation pattern of the affected hand movement was gradually restored to normal. Conclusion A case of good motor recovery after stroke due to HA injection with a lesion mainly restricted to the precentral gyrus but without CST damage is presented in the current study. Further studies should be conducted to explore the efficacy and the mechanisms of rehabilitation and neuromodulation approaches to motor cortical stroke.
Collapse
Affiliation(s)
- Xinwei Tang
- Department of Rehabilitation Medicine, Huashan Hospital, Fudan University, Shanghai, China
| | - Qiurong Yu
- Shanghai Key Laboratory of Magnetic Resonance, School of Physics and Electronic Science, East China Normal University, Shanghai, China
| | - Miao Guo
- Shanghai Key Laboratory of Magnetic Resonance, School of Physics and Electronic Science, East China Normal University, Shanghai, China
| | - Fan Liu
- Shanghai Key Laboratory of Magnetic Resonance, School of Physics and Electronic Science, East China Normal University, Shanghai, China
| | - Yongquan Pan
- Department of Rehabilitation Medicine, Huashan Hospital, Fudan University, Shanghai, China
| | - Jingyuan Zhou
- Department of Rehabilitation Medicine, Huashan Hospital, Fudan University, Shanghai, China
| | - Yue Zou
- Department of Rehabilitation Medicine, Huashan Hospital, Fudan University, Shanghai, China
| | - Cheng Wu
- Department of Rehabilitation Medicine, Huashan Hospital, Fudan University, Shanghai, China
| | - Kewei Yu
- Department of Rehabilitation Medicine, Huashan Hospital, Fudan University, Shanghai, China
| | - Mingxia Fan
- Shanghai Key Laboratory of Magnetic Resonance, School of Physics and Electronic Science, East China Normal University, Shanghai, China
| | - Limin Sun
- Department of Rehabilitation Medicine, Huashan Hospital, Fudan University, Shanghai, China
- *Correspondence: Limin Sun
| |
Collapse
|
5
|
Juli C, Heryaman H, Arnengsih, Ang ET, Defi IR, Gamayani U, Atik N. The number of risk factors increases the recurrence events in ischemic stroke. Eur J Med Res 2022; 27:138. [PMID: 35918760 PMCID: PMC9344667 DOI: 10.1186/s40001-022-00768-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2022] [Accepted: 07/18/2022] [Indexed: 11/10/2022] Open
Abstract
PURPOSE Stroke is a significant cause of disability worldwide and is considered a disease caused by long-term exposure to lifestyle-related risk factors. These risk factors influence the first event of stroke and recurrent stroke events, which carry more significant risks for more severe disabilities. This study specifically compared the risk factors and neurological outcome of patients with recurrent ischemic stroke to those who had just experienced their first stroke among patients admitted to the Hospital. PATIENTS AND METHODS We observed and analyzed 300 patients' data who met the inclusion and exclusion criteria. This retrospective observational study was conducted on consecutive acute ischemic stroke patients admitted to the top referral hospital, West Java, Indonesia. The data displayed are epidemiological characteristics, NIHSS score at admission and discharge, and the type and number of risk factors. Data were then analyzed using appropriate statistical tests. RESULTS Most patients had more than one risk factor with hypertension as the most frequent (268 subjects or 89.3%). In patients who experienced ischemic stroke for the first time, the average National Institutes of Health Stroke Scale (NIHSS) score was lower (6.52 ± 3.55), and the alteration of NIHSS score was higher (1.22 ± 2.26) than those with recurrent stroke (6.96 ± 3.55) for NIHSS score and 1.21 ± 1.73 for alteration of NIHSS score). We processed the data with statistical analysis and showed a positive correlation between age (P < 0.05) and the number of risk factors (P < 0.001) in the recurrent ischemic stroke group. CONCLUSIONS Age and the number of risk factors correlate with recurrent ischemic strokes.
Collapse
Affiliation(s)
- Cep Juli
- Doctoral Program, Faculty of Medicine, Padjadjaran University, Bandung, Indonesia.,Department of Neurology Dr. Hasan Sadikin General Hospital/Faculty of Medicine, Padjadjaran University, Bandung, Indonesia
| | - Henhen Heryaman
- Doctoral Program, Faculty of Medicine, Padjadjaran University, Bandung, Indonesia
| | - Arnengsih
- Doctoral Program, Faculty of Medicine, Padjadjaran University, Bandung, Indonesia
| | - Eng-Tat Ang
- Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Bandung, Singapore
| | - Irma Ruslina Defi
- Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Dr. Hasan Sadikin General Hospital, Padjadjaran University, Bandung, Indonesia
| | - Uni Gamayani
- Department of Neurology Dr. Hasan Sadikin General Hospital/Faculty of Medicine, Padjadjaran University, Bandung, Indonesia
| | - Nur Atik
- Department of Biomedical Sciences, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.
| |
Collapse
|
6
|
Effectiveness of kinesiology taping on the functions of upper limbs in patients with stroke: a meta-analysis of randomized trial. Neurol Sci 2022; 43:4145-4156. [PMID: 35347525 PMCID: PMC9213317 DOI: 10.1007/s10072-022-06010-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2021] [Accepted: 03/06/2022] [Indexed: 11/17/2022]
Abstract
Background Kinesiology tape (KT), a water-resistant and elastic tape which is well known measure for preventing musculoskeletal injuries, has recently gained popularity in neurological rehabilitation. This is a systematic and meta-analysis study, useful both to evaluate the efficacy of kinesiology taping on the functions of upper limbs in patients with stroke and to collect the main outcomes evaluated in the analyzed studies. Methods A comprehensive literature search of electronic databases including Medline, Web of science, Embase, Cochrane Central Register of Controlled Trials, Physiotherapy Evidence Database (PEDro), WANFANG, and the China National Knowledge Infrastructure (CNKI). Additional articles were obtained by scanning reference lists of included studies and previous reviews. Keywords were “kinesiology taping,” “kinesio,” “kinesio taping,” “tape” and “stroke,” “hemiplegia,” “hemiplegic paralysis,” “apoplexy,” “hemiparesis,” “upper extremity,” “upper limb.” All the RCTs were included. Quality assessment was performed using Cochrane criteria. Upper extremity function and pain intensity was pooled as the primary outcome, and shoulder subluxation, muscle spasticity, general disability, PROM of abduction, and adverse effects as secondary outcomes. Results Twelve articles were included. Pooled data provided evidence that there was significance between kinesiology taping groups and control groups in pain intensity (standardized mean difference − 0.79, 95% CI − 1.39 to − 0.19), shoulder subluxation (standardized mean difference − 0.50, 95%CI − 0.80 to − 0.20), general disability (standardized mean difference 0.35, 95%CI 0.10 to 0.59), upper extremity function (standardized mean difference 0.61, 95%CI 0.18 to 1.04), and the PROM of flexion (standardized mean difference 0.63, 95%CI 0.28 to 0.98). Conclusion Current evidence suggested that kinesiology taping could be recommended to improve upper limb function in patients with stroke in pain intensity, shoulder subluxation, general disability, upper extremity function, and the PROM of flexion. Ethics and dissemination Ethical approval requirements are not necessary for this review. This systematic review and meta-analysis will be disseminated online and on paper to help guide the clinical practice better. PROSPERO registration number CRD42020179762.
Collapse
|
7
|
Salgueiro C, Urrútia G, Cabanas-Valdés R. Influence of Core-Stability Exercises Guided by a Telerehabilitation App on Trunk Performance, Balance and Gait Performance in Chronic Stroke Survivors: A Preliminary Randomized Controlled Trial. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2022; 19:5689. [PMID: 35565084 PMCID: PMC9101754 DOI: 10.3390/ijerph19095689] [Citation(s) in RCA: 10] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/09/2022] [Revised: 05/02/2022] [Accepted: 05/05/2022] [Indexed: 12/21/2022]
Abstract
Stroke is one of the main causes of disability. Telerehabilitation could face the growing demand and a good strategy for post-stroke rehabilitation. The aim of this study is to examine the possible effects of therapeutic exercises performed by an App on trunk control, balance, and gait in stroke survivors. A preliminary 12-week randomized controlled trial was developed. Thirty chronic stroke survivors were randomly allocated into two groups. Both groups performed conventional physiotherapy, in addition to, the experimental group (EG) had access to a telerehabilitation App to guide home-based core-stability exercises (CSE). Trunk performance was measured with the Spanish-Trunk Impairment Scale (S-TIS 2.0) and Spanish-Function in Sitting Test. Balance and gait were measured with Spanish-Postural Assessment Scale for Stroke patient, Berg Balance Scale and an accelerometer system. In EG was observed an improvement of 2.76 points in S-TIS 2.0 (p = 0.001). Small differences were observed in balance and gait. Adherence to the use of the App was low. CSE guided by a telerehabilitation App, combined with conventional physiotherapy, seem to improve trunk function and sitting balance in chronic post-stroke. Active participation in the rehabilitation process should be increased among stroke survivors. Further confirmatory studies are necessary with a large sample size.
Collapse
Affiliation(s)
- Carina Salgueiro
- Physiotherapy Department, Faculty of Medicine and Health Science Campus Sant Cugat, Universitat Internacional de Catalunya, 08195 Barcelona, Spain;
| | - Gerard Urrútia
- Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau), CIBER de Epidemiología y Salud Pública (CIBERESP), 08025 Barcelona, Spain;
| | - Rosa Cabanas-Valdés
- Physiotherapy Department, Faculty of Medicine and Health Science Campus Sant Cugat, Universitat Internacional de Catalunya, 08195 Barcelona, Spain;
| |
Collapse
|
8
|
Sousa ASP, Moreira J, Silva C, Mesquita I, Macedo R, Silva A, Santos R. Usability of Functional Electrical Stimulation in Upper Limb Rehabilitation in Post-Stroke Patients: A Narrative Review. SENSORS 2022; 22:s22041409. [PMID: 35214311 PMCID: PMC8963083 DOI: 10.3390/s22041409] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/21/2021] [Revised: 02/09/2022] [Accepted: 02/10/2022] [Indexed: 12/10/2022]
Abstract
Stroke leads to significant impairment in upper limb (UL) function. The goal of rehabilitation is the reestablishment of pre-stroke motor stroke skills by stimulating neuroplasticity. Among several rehabilitation approaches, functional electrical stimulation (FES) is highlighted in stroke rehabilitation guidelines as a supplementary therapy alongside the standard care modalities. The aim of this study is to present a comprehensive review regarding the usability of FES in post-stroke UL rehabilitation. Specifically, the factors related to UL rehabilitation that should be considered in FES usability, as well a critical review of the outcomes used to assess FES usability, are presented. This review reinforces the FES as a promising tool to induce neuroplastic modifications in post-stroke rehabilitation by enabling the possibility of delivering intensive periods of treatment with comparatively less demand on human resources. However, the lack of studies evaluating FES usability through motor control outcomes, specifically movement quality indicators, combined with user satisfaction limits the definition of FES optimal therapeutical window for different UL functional tasks. FES systems capable of integrating postural control muscles involving other anatomic regions, such as the trunk, during reaching tasks are required to improve UL function in post-stroke patients.
Collapse
Affiliation(s)
- Andreia S. P. Sousa
- Center for Rehabilitation Research—Human Movement System (Re)habilitation Area, Department of Physiotherapy, School of Health, Polytechnic of Porto, Rua Dr. António Bernardino de Almeida 400, 4200-072 Porto, Portugal; (J.M.); (C.S.); (R.M.); (A.S.)
- Correspondence: or ; Tel.: +351-222-061-000
| | - Juliana Moreira
- Center for Rehabilitation Research—Human Movement System (Re)habilitation Area, Department of Physiotherapy, School of Health, Polytechnic of Porto, Rua Dr. António Bernardino de Almeida 400, 4200-072 Porto, Portugal; (J.M.); (C.S.); (R.M.); (A.S.)
| | - Cláudia Silva
- Center for Rehabilitation Research—Human Movement System (Re)habilitation Area, Department of Physiotherapy, School of Health, Polytechnic of Porto, Rua Dr. António Bernardino de Almeida 400, 4200-072 Porto, Portugal; (J.M.); (C.S.); (R.M.); (A.S.)
| | - Inês Mesquita
- Center for Rehabilitation Research—Human Movement System (Re)habilitation Area, Department of Functional Sciences, School of Health, Polytechnic of Porto, Rua Dr. António Bernardino de Almeida 400, 4200-072 Porto, Portugal;
| | - Rui Macedo
- Center for Rehabilitation Research—Human Movement System (Re)habilitation Area, Department of Physiotherapy, School of Health, Polytechnic of Porto, Rua Dr. António Bernardino de Almeida 400, 4200-072 Porto, Portugal; (J.M.); (C.S.); (R.M.); (A.S.)
| | - Augusta Silva
- Center for Rehabilitation Research—Human Movement System (Re)habilitation Area, Department of Physiotherapy, School of Health, Polytechnic of Porto, Rua Dr. António Bernardino de Almeida 400, 4200-072 Porto, Portugal; (J.M.); (C.S.); (R.M.); (A.S.)
| | - Rubim Santos
- Center for Rehabilitation Research—Human Movement System (Re)habilitation Area, Department of Physics, School of Health, Polytechnic of Porto, Rua Dr. António Bernardino de Almeida 400, 4200-072 Porto, Portugal;
| |
Collapse
|
9
|
Saionz EL, Busza A, Huxlin KR. Rehabilitation of visual perception in cortical blindness. HANDBOOK OF CLINICAL NEUROLOGY 2022; 184:357-373. [PMID: 35034749 PMCID: PMC9682408 DOI: 10.1016/b978-0-12-819410-2.00030-8] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Blindness is a common sequela after stroke affecting the primary visual cortex, presenting as a contralesional, homonymous, visual field cut. This can occur unilaterally or, less commonly, bilaterally. While it has been widely assumed that after a brief period of spontaneous improvement, vision loss becomes stable and permanent, accumulating data show that visual training can recover some of the vision loss, even long after the stroke. Here, we review the different approaches to rehabilitation employed in adult-onset cortical blindness (CB), focusing on visual restoration methods. Most of this work was conducted in chronic stroke patients, partially restoring visual discrimination and luminance detection. However, to achieve this, patients had to train for extended periods (usually many months), and the vision restored was not entirely normal. Several adjuvants to training such as noninvasive, transcranial brain stimulation, and pharmacology are starting to be investigated for their potential to increase the efficacy of training in CB patients. However, these approaches are still exploratory and require considerably more research before being adopted. Nonetheless, having established that the adult visual system retains the capacity for restorative plasticity, attention recently turned toward the subacute poststroke period. Drawing inspiration from sensorimotor stroke rehabilitation, visual training was recently attempted for the first time in subacute poststroke patients. It improved vision faster, over larger portions of the blind field, and for a larger number of visual discrimination abilities than identical training initiated more than 6 months poststroke (i.e., in the chronic period). In conclusion, evidence now suggests that visual neuroplasticity after occipital stroke can be reliably recruited by a range of visual training approaches. In addition, it appears that poststroke visual plasticity is dynamic, with a critical window of opportunity in the early postdamage period to attain more rapid, more extensive recovery of a larger set of visual perceptual abilities.
Collapse
Affiliation(s)
- Elizabeth L Saionz
- Medical Scientist Training Program, University of Rochester, Rochester, NY, United States
| | - Ania Busza
- Department of Neurology, University of Rochester, Rochester, NY, United States
| | - Krystel R Huxlin
- Flaum Eye Institute, University of Rochester, Rochester, NY, United States.
| |
Collapse
|
10
|
Selvaraj UM, Ujas TA, Kong X, Kumar A, Plautz EJ, Zhang S, Xing C, Sudduth TL, Wilcock DM, Turchan-Cholewo J, Goldberg MP, Stowe AM. Delayed diapedesis of CD8 T cells contributes to long-term pathology after ischemic stroke in male mice. Brain Behav Immun 2021; 95:502-513. [PMID: 33964435 PMCID: PMC8221572 DOI: 10.1016/j.bbi.2021.05.001] [Citation(s) in RCA: 30] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/31/2020] [Revised: 04/14/2021] [Accepted: 05/03/2021] [Indexed: 12/11/2022] Open
Abstract
OBJECTIVE Stroke is a debilitating disorder with significant annual mortality and morbidity rates worldwide. Immune cells are recruited to the injured brain within hours after stroke onset and can exhibit either protective or detrimental effects on recovery. However, immune cells, including CD8 T cells, persist in the injured brain for weeks, suggesting a longer-term role for the adaptive immune system during functional recovery. The aim of this study was to determine if the delayed secondary diapedesis of CD8 T cells into the ischemic brain negatively impacts functional recovery after transient ischemic stroke in male mice. RESULTS Mice exhibited an increased number of leukocytes in the ipsilesional hemispheres at 14 days (3-fold; p < 0.001) and 30 days (2.2-fold; p = 0.02) after transient middle cerebral artery occlusion (tMCAo) compared to 8 days post-tMCAo, at which time acute neuroinflammation predominantly resolves. Moreover, mice with higher ipsilesional CD8 T cells at 30 days (R2 = 0.52, p < 0.01) exhibited worse functional recovery. To confirm a detrimental role of chronic CD8 T cell diapedesis on recovery, peripheral CD8 T cells were depleted beginning 10 days post-tMCAo. Delayed CD8 T cell depletion improved motor recovery on the rotarod (F(1,28) = 4.264; p = 0.048) compared to isotype control-treated mice. CD8 T cell-depleted mice also exhibited 2-fold (p < 0.001) reduced leukocyte infiltration at 30 days post-tMCAo. Specifically, macrophage, neutrophil, and CD4 T cell numbers were reduced in the ipsilesional hemisphere of the CD8 T cell-depleted mice independent of inflammatory status of the post-stroke CNS (e.g. microglial phenotype and cytokine production). RNAseq identified a unique profile for brain infiltrating CD8 T cells at 30 days post-tMCAo, with 46 genes differentially expressed relative to CD8 T cells at 3 days post-tMCAo. CONCLUSION Our data reveal a role for CD8 T cells in the chronic phase post-stroke that can be therapeutically targeted. We demonstrate long-term CD8 T cell recruitment into the ipsilesional hemisphere that affects both immune cell numbers present in the injured brain and functional recovery through one month after stroke onset.
Collapse
Affiliation(s)
- Uma Maheswari Selvaraj
- Department of Neurology & Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, TX, United States
| | - Thomas A Ujas
- Department of Neurology, Center for Advanced Translational Stroke Science, University of Kentucky, Lexington, KY, United States
| | - Xiangmei Kong
- Department of Neurology & Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, TX, United States
| | - Ashwani Kumar
- Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, TX, United States
| | - Erik J Plautz
- Department of Neurology & Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, TX, United States
| | - Shanrong Zhang
- Advanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, TX, United States
| | - Chao Xing
- Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, TX, United States; Department of Bioinformatics, University of Texas Southwestern Medical Center, Dallas, TX, United States; Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, TX, United States
| | - Tiffany L Sudduth
- Department of Physiology, Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY, United States
| | - Donna M Wilcock
- Department of Physiology, Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY, United States
| | - Jadwiga Turchan-Cholewo
- Department of Neurology, Center for Advanced Translational Stroke Science, University of Kentucky, Lexington, KY, United States
| | - Mark P Goldberg
- Department of Neurology & Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, TX, United States
| | - Ann M Stowe
- Department of Neurology & Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, TX, United States; Department of Neurology, Center for Advanced Translational Stroke Science, University of Kentucky, Lexington, KY, United States.
| |
Collapse
|
11
|
Chu SA, Chen TY, Chen PY, Tzeng WJ, Liang CL, Lu K, Chen HJ, Wu CC, Chen JH, Tsai CC, Wang HK. Acupuncture May Decrease the Incidence of Post-stroke Dementia: A Taiwan Nationwide Retrospective Cohort Study. Front Neurol 2021; 12:657048. [PMID: 34093405 PMCID: PMC8176024 DOI: 10.3389/fneur.2021.657048] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2021] [Accepted: 04/30/2021] [Indexed: 12/11/2022] Open
Abstract
Background: Post-stroke dementia may affect up to one-third of stroke survivors. Acupuncture as a complementary treatment for stroke has been shown to be beneficial for subsequent post-stroke rehabilitation. The purpose of this retrospective cohort study was to investigate the potential effect of acupuncture to protect stroke patients from dementia. Methods: We included 9,547 patients receiving ambulatory or hospital care for stroke and 9.547 non-stroke patients; patients were matched for sex, age, and Charlson Comorbidity Index. Each individual was traced for the subsequent development of dementia. Two thousand four hundred and forty-nine stroke patients received acupuncture treatment and 7,098 residue stroke patients without acupuncture treatment served as control groups. This is a 3-year follow-up cohorts study: the incidence and adjusted hazard ratios (HRs) with 95% confidence intervals (CIs) of post- stroke dementia in the Cox proportional hazard regression. Results: During the 3-year follow-up, 1,403 patients with stroke (14.70%) and 427 patients without stroke (4.47%) developed dementia. The adjusted HRs of development of dementia among stroke patients were 3.64-times (range, 3.27–4.06), and the incidence of dementia was higher in male. Stroke patients receiving acupuncture treatment had a lower probability of dementia than those without acupuncture during the follow-up period, the adjusted HRs was 0.49 (95% CI, 0.42–0.58; p < 0.001). Conclusions: The association between stroke and dementia existed in both sexes, more prominent in male. Patients with stroke receiving acupuncture treatments showed decreased risk of dementia. Care must be taken evaluating these results because this study was limited to lack of information regarding lifestyles, stroke severities, and acupuncture methods that were used in treatments.
Collapse
Affiliation(s)
- Shao-Ang Chu
- Department of Neurosurgery, E-Da Hospital, Kaohsiung, Taiwan.,School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan
| | - Te-Yuan Chen
- Department of Neurosurgery, E-Da Hospital, Kaohsiung, Taiwan.,School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan
| | - Po-Yuan Chen
- Department of Neurosurgery, E-Da Hospital, Kaohsiung, Taiwan.,School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan
| | - Wei-Jie Tzeng
- Department of Neurosurgery, E-Da Hospital, Kaohsiung, Taiwan.,School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan
| | - Cheng-Loong Liang
- Department of Neurosurgery, E-Da Hospital, Kaohsiung, Taiwan.,School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan
| | - Kang Lu
- Department of Neurosurgery, E-Da Hospital, Kaohsiung, Taiwan.,School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan
| | - Han-Jung Chen
- Department of Neurosurgery, E-Da Hospital, Kaohsiung, Taiwan.,School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan
| | - Cheng-Chun Wu
- Department of Neurosurgery, E-Da Hospital, Kaohsiung, Taiwan.,School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan
| | - Jian-Han Chen
- School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan.,Department of General Surgery, E-Da Hospital, Kaohsiung, Taiwan
| | - Chin-Chuan Tsai
- Chinese Medicine Department, E-Da Hospital, Kaohsiung, Taiwan.,School of Chinese Medicine for Post-Baccalaureates, I-Shou University, Kaohsiung, Taiwan
| | - Hao-Kuang Wang
- Department of Neurosurgery, E-Da Hospital, Kaohsiung, Taiwan.,School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan
| |
Collapse
|
12
|
Vijayan M, Reddy PH. Non-Coding RNAs Based Molecular Links in Type 2 Diabetes, Ischemic Stroke, and Vascular Dementia. J Alzheimers Dis 2021; 75:353-383. [PMID: 32310177 DOI: 10.3233/jad-200070] [Citation(s) in RCA: 20] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
This article reviews recent advances in the study of microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and their functions in type 2 diabetes mellitus (T2DM), ischemic stroke (IS), and vascular dementia (VaD). miRNAs and lncRNAs are gene regulation markers that both regulate translational aspects of a wide range of proteins and biological processes in healthy and disease states. Recent studies from our laboratory and others have revealed that miRNAs and lncRNAs expressed differently are potential therapeutic targets for neurological diseases, especially T2DM, IS, VaD, and Alzheimer's disease (AD). Currently, the effect of aging in T2DM, IS, and VaD and the cellular and molecular pathways are largely unknown. In this article, we highlight results from the works on the molecular connections between T2DM and IS, and IS and VaD. In each disease, we also summarize the pathophysiology and the differential expressions of miRNAs and lncRNAs. Based on current research findings, we hypothesize that 1) T2DM bi-directionally and age-dependently induces IS and VaD, and 2) these changes are precursors to the onset of dementia in elderly people. Research into these hypotheses is required to examine further whether research efforts on reducing T2DM, IS, and VaD may affect dementia and/or delay the AD disease process in the aged population.
Collapse
Affiliation(s)
- Murali Vijayan
- Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA
| | - P Hemachandra Reddy
- Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.,Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX, USA.,Department of Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, Lubbock, TX, USA.,Department of Neurology, Texas Tech University Health Sciences Center, Lubbock, TX, USA.,Department of Speech, Language and Hearing Sciences, Texas Tech University Health Sciences Center, Lubbock, TX, USA.,Department of Public Health, Graduate School of Biomedical Sciences, Texas Tech University Health Sciences Center, Lubbock, TX, USA
| |
Collapse
|
13
|
Wang X, Huang X, Yang M, Pan X, Duan M, Cai H, Jiang G, Wen X, Zou D, Chen L. Tongxinluo promotes axonal plasticity and functional recovery after stroke. Transl Neurosci 2020; 11:428-438. [PMID: 33335781 PMCID: PMC7718613 DOI: 10.1515/tnsci-2020-0127] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2020] [Revised: 08/24/2020] [Accepted: 08/26/2020] [Indexed: 11/23/2022] Open
Abstract
Background The aim of this study was to investigate the neural plasticity in contralesional cortex and the effects of tongxinluo (TXL) in cerebral ischemic rats. Methodology We used stroke-prone renovascular hypertensive (RHRSP) cerebral ischemia rat models to study the effect of TXL and the underlying mechanisms. We performed foot-fault and beam-walking tests to evaluate the motor function of rats after cortical infarction. Biotinylated dextran amine (BDA) was used to track axonal sprouting and neural connections. Results TXL enhanced the recovery of motor function in cerebral infarction rats. TXL increased axonal sprouting in the peri-infarcted area but not in the corpus callosum, indicating in situ origination instead of crossing between cortical hemispheres through the corpus callosum. TXL promoted the sprouting of corticospinal axons into the denervated side of spinal gray matter. The synaptophysin (SYN)-positive intensity in the peri-infarcted area of TXL-treated group was greater than that in the vehicle group. We observed co-localization of SYN with BDA-positive fibers in the denervated spinal cord gray matter in the TXL group, suggesting that axonal remodeling and synaptic connections were promoted by TXL. Conclusion TXL may promote the recovery of neurological function by promoting the axonal remodeling and synapse formation of motor neuronal fibers after focal cortical infarction in hypertensive rats.
Collapse
Affiliation(s)
- Xiaoting Wang
- Department of Neurology, Wuzhou Red Cross Hospital, Wuzhou, Guangxi Zhuang Autonomous Region, 543002, China
| | - Xiaoqin Huang
- Department of Neurology, the First Affiliated Hospital of Guangxi Medical University , Nanning, Guangxi Zhuang Autonomous Region, 530021, China
| | - Mengqi Yang
- Department of Neurology, the First Affiliated Hospital of Guangxi Medical University , Nanning, Guangxi Zhuang Autonomous Region, 530021, China
| | - Xueying Pan
- Department of Neurology, the First Affiliated Hospital of Guangxi Medical University , Nanning, Guangxi Zhuang Autonomous Region, 530021, China
| | - Meiyi Duan
- Department of Neurology, the First Affiliated Hospital of Guangxi Medical University , Nanning, Guangxi Zhuang Autonomous Region, 530021, China
| | - Hui Cai
- Department of Neurology, the First Affiliated Hospital of Guangxi Medical University , Nanning, Guangxi Zhuang Autonomous Region, 530021, China
| | - Guimiao Jiang
- Department of Neurology, the First Affiliated Hospital of Guangxi Medical University , Nanning, Guangxi Zhuang Autonomous Region, 530021, China
| | - Xianlong Wen
- Department of Neurology, the First Affiliated Hospital of Guangxi Medical University , Nanning, Guangxi Zhuang Autonomous Region, 530021, China
| | - Donghua Zou
- Department of Neurology, the Fifth Affiliated Hospital of Guangxi Medical University , Nanning, Guangxi Zhuang Autonomous Region, 530021, China
| | - Li Chen
- Department of Neurology, the First Affiliated Hospital of Guangxi Medical University , Nanning, Guangxi Zhuang Autonomous Region, 530021, China
- Guangxi Key Laboratory of Regenerative Medicine and Guangxi Collaborative Innovation Center for Biomedicine, Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, 530021, China
| |
Collapse
|
14
|
Lee SH, Kim SS, Lee BH. Action observation training and brain-computer interface controlled functional electrical stimulation enhance upper extremity performance and cortical activation in patients with stroke: a randomized controlled trial. Physiother Theory Pract 2020; 38:1126-1134. [PMID: 33026895 DOI: 10.1080/09593985.2020.1831114] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
PURPOSE Brain-computer interface (BCI)-functional electronic stimulation (FES) systems are increasingly being explored as potential neuro-rehabilitation tools. Here, we investigate the effect of action observation training (AOT) plus electroencephalogram (EEG)-based BCI-controlled FES system on motor recovery of upper extremity and cortical activation in patients with stroke. METHOD There were a total of 26 patients: an AOT plus BCI-FES group (n = 13) and a control group (n = 13). The control group performed FES treatment and the conventional physical therapy, while the AOT plus BCI-FES group performed AOT plus BCI-FES and the conventional physical therapy. Upper extremity performance was measured using the Fugl-Meyer Assessment of the Upper Extremity (FMA-UE), Wolf Motor Function Test (WMFT), Motor Activity Log (MAL) and Modified Barthel Index (MBI). Cortical activation was measured using electro-encephalographic recordings from alpha and beta power, concentration, and activation. RESULTS After intervention, there were significant differences between two groups in FMA-UE, WMFT, MAL and MBI and the results of EEG including alpha power, beta power, concentration and activation. CONCLUSIONS This study demonstrated that AOT plus BCI-FES can enhance motor function of upper extremity and cortical activation in patients with stroke. This training method may be feasible and suitable for individuals with stroke.
Collapse
Affiliation(s)
- Su-Hyun Lee
- Department of Physical Therapy, Sahmyook University, Seoul, Korea
| | - Seong Sik Kim
- Department of Physical Therapy, Sahmyook University, Seoul, Korea
| | - Byoung-Hee Lee
- Department of Physical Therapy, Sahmyook University, Seoul, Korea
| |
Collapse
|
15
|
Neurobiology of Recovery of Motor Function after Stroke: The Central Nervous System Biomarker Effects of Constraint-Induced Movement Therapy. Neural Plast 2020; 2020:9484298. [PMID: 32617098 PMCID: PMC7312560 DOI: 10.1155/2020/9484298] [Citation(s) in RCA: 21] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/01/2019] [Revised: 02/25/2019] [Accepted: 10/31/2019] [Indexed: 12/31/2022] Open
Abstract
Recovery of motor function after stroke involves many biomarkers. This review attempts to identify the biomarker effects responsible for recovery of motor function following the use of Constraint-Induced Movement Therapy (CIMT) and discuss their implications for research and practice. From the studies reviewed, the biomarker effects identified include improved perfusion of motor areas and brain glucose metabolism; increased expression of proteins, namely, Brain-Derived Neurotrophic Factor (BDNF), Vascular Endothelial Growth Factor (VEGF), and Growth-Associated Protein 43 (GAP-43); and decreased level of Gamma-Aminobutyric Acid (GABA). Others include increased cortical activation, increased motor map size, and decreased interhemispheric inhibition of the ipsilesional hemisphere by the contralesional hemisphere. Interestingly, the biomarker effects correlated well with improved motor function. However, some of the biomarker effects have not yet been investigated in humans, and they require that CIMT starts early on poststroke. In addition, one study seems to suggest the combined use of CIMT with other rehabilitation techniques such as Transcortical Direct Stimulation (tDCs) in patients with chronic stroke to achieve the biomarker effects. Unfortunately, there are few studies in humans that implemented CIMT during early poststroke. Thus, it is important that more studies in humans are carried out to determine the biomarker effects of CIMT especially early on poststroke, when there is a greater opportunity for recovery. Furthermore, it should be noted that these effects are mainly in ischaemic stroke.
Collapse
|
16
|
Saionz EL, Tadin D, Melnick MD, Huxlin KR. Functional preservation and enhanced capacity for visual restoration in subacute occipital stroke. Brain 2020; 143:1857-1872. [PMID: 32428211 PMCID: PMC7296857 DOI: 10.1093/brain/awaa128] [Citation(s) in RCA: 31] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2019] [Revised: 01/30/2020] [Accepted: 03/01/2020] [Indexed: 01/18/2023] Open
Abstract
Stroke damage to the primary visual cortex (V1) causes a loss of vision known as hemianopia or cortically-induced blindness. While perimetric visual field improvements can occur spontaneously in the first few months post-stroke, by 6 months post-stroke, the deficit is considered chronic and permanent. Despite evidence from sensorimotor stroke showing that early injury responses heighten neuroplastic potential, to date, visual rehabilitation research has focused on patients with chronic cortically-induced blindness. Consequently, little is known about the functional properties of the post-stroke visual system in the subacute period, nor do we know if these properties can be harnessed to enhance visual recovery. Here, for the first time, we show that 'conscious' visual discrimination abilities are often preserved inside subacute, perimetrically-defined blind fields, but they disappear by ∼6 months post-stroke. Complementing this discovery, we now show that training initiated subacutely can recover global motion discrimination and integration, as well as luminance detection perimetry, just as it does in chronic cortically-induced blindness. However, subacute recovery was attained six times faster; it also generalized to deeper, untrained regions of the blind field, and to other (untrained) aspects of motion perception, preventing their degradation upon reaching the chronic period. In contrast, untrained subacutes exhibited spontaneous improvements in luminance detection perimetry, but spontaneous recovery of motion discriminations was never observed. Thus, in cortically-induced blindness, the early post-stroke period appears characterized by gradual-rather than sudden-loss of visual processing. Subacute training stops this degradation, and is far more efficient at eliciting recovery than identical training in the chronic period. Finally, spontaneous visual improvements in subacutes were restricted to luminance detection; discrimination abilities only recovered following deliberate training. Our findings suggest that after V1 damage, rather than waiting for vision to stabilize, early training interventions may be key to maximize the system's potential for recovery.
Collapse
Affiliation(s)
- Elizabeth L Saionz
- Flaum Eye Institute, University of Rochester, Rochester, NY, USA
- Medical Scientist Training Program, University of Rochester, Rochester, NY, USA
| | - Duje Tadin
- Flaum Eye Institute, University of Rochester, Rochester, NY, USA
- Department of Brain and Cognitive Sciences, University of Rochester, Rochester, NY, USA
| | - Michael D Melnick
- Flaum Eye Institute, University of Rochester, Rochester, NY, USA
- Department of Brain and Cognitive Sciences, University of Rochester, Rochester, NY, USA
| | - Krystel R Huxlin
- Flaum Eye Institute, University of Rochester, Rochester, NY, USA
- Department of Brain and Cognitive Sciences, University of Rochester, Rochester, NY, USA
| |
Collapse
|
17
|
Tsintou M, Dalamagkas K, Makris N. Taking central nervous system regenerative therapies to the clinic: curing rodents versus nonhuman primates versus humans. Neural Regen Res 2020; 15:425-437. [PMID: 31571651 PMCID: PMC6921352 DOI: 10.4103/1673-5374.266048] [Citation(s) in RCA: 25] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2019] [Accepted: 06/04/2019] [Indexed: 12/17/2022] Open
Abstract
The central nervous system is known to have limited regenerative capacity. Not only does this halt the human body's reparative processes after central nervous system lesions, but it also impedes the establishment of effective and safe therapeutic options for such patients. Despite the high prevalence of stroke and spinal cord injury in the general population, these conditions remain incurable and place a heavy burden on patients' families and on society more broadly. Neuroregeneration and neural engineering are diverse biomedical fields that attempt reparative treatments, utilizing stem cells-based strategies, biologically active molecules, nanotechnology, exosomes and highly tunable biodegradable systems (e.g., certain hydrogels). Although there are studies demonstrating promising preclinical results, safe clinical translation has not yet been accomplished. A key gap in clinical translation is the absence of an ideal animal or ex vivo model that can perfectly simulate the human microenvironment, and also correspond to all the complex pathophysiological and neuroanatomical factors that affect functional outcomes in humans after central nervous system injury. Such an ideal model does not currently exist, but it seems that the nonhuman primate model is uniquely qualified for this role, given its close resemblance to humans. This review considers some regenerative therapies for central nervous system repair that hold promise for future clinical translation. In addition, it attempts to uncover some of the main reasons why clinical translation might fail without the implementation of nonhuman primate models in the research pipeline.
Collapse
Affiliation(s)
- Magdalini Tsintou
- Departments of Psychiatry and Neurology Services, Center for Neural Systems Investigations, Center for Morphometric Analysis, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
- Department of Psychiatry, Psychiatry Neuroimaging Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
- University College of London Division of Surgery & Interventional Science, Center for Nanotechnology & Regenerative Medicine, University College London, London, UK
| | - Kyriakos Dalamagkas
- University College of London Division of Surgery & Interventional Science, Center for Nanotechnology & Regenerative Medicine, University College London, London, UK
- Department of Physical Medicine and Rehabilitation, The University of Texas Health Science Center at Houston, Houston, TX, USA
- The Institute for Rehabilitation and Research Memorial Hermann Research Center, The Institute for Rehabilitation and Research Memorial Hermann Hospital, Houston, TX, USA
| | - Nikos Makris
- Departments of Psychiatry and Neurology Services, Center for Neural Systems Investigations, Center for Morphometric Analysis, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
- Department of Psychiatry, Psychiatry Neuroimaging Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
- Department of Anatomy & Neurobiology, Boston University School of Medicine, Boston, MA, USA
| |
Collapse
|
18
|
Versace V, Schwenker K, Langthaler PB, Golaszewski S, Sebastianelli L, Brigo F, Pucks-Faes E, Saltuari L, Nardone R. Facilitation of Auditory Comprehension After Theta Burst Stimulation of Wernicke's Area in Stroke Patients: A Pilot Study. Front Neurol 2020; 10:1319. [PMID: 31969857 PMCID: PMC6960103 DOI: 10.3389/fneur.2019.01319] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2019] [Accepted: 11/28/2019] [Indexed: 12/27/2022] Open
Abstract
Introduction: Single-pulse transcranial magnetic stimulation (TMS) and high-frequency repetitive TMS (rTMS) over Wernicke's area were found to facilitate language functions in right-handed healthy subjects. We aimed at investigating the effects of excitatory rTMS, given as intermittent theta burst stimulation (iTBS) over left Wernicke's area, on auditory comprehension in patients suffering from fluent aphasia after stroke of the left temporal lobe. Methods: We studied 13 patients with chronic fluent aphasia after an ischemic stroke involving Wernicke's area. iTBS was applied in random order to Wernicke's area, the right-hemisphere homologous of Wernicke's area, and the primary visual cortex. Auditory comprehension was blind assessed using the Token test before (T0), 5 (T1), and 40 min (T2) after a single session of iTBS. Results: At the first evaluation (T1) after iTBS on left Wernike's area, but not on the contralateral homologous area nor on the primary visual cortex, the scores on the Token test were significantly increased. No significant effects were observed at T2. Conclusion: We demonstrated that a single session of excitatory iTBS over Wernicke's area was safe and led to a transient facilitation of auditory comprehension in chronic stroke patients with lesions in the same area. Further studies are needed to establish whether TBS-induced modulation can be enhanced and transformed into longer-lasting effects by means of repeated TBS sessions and by combining TBS with speech and language therapy.
Collapse
Affiliation(s)
- Viviana Versace
- Department of Neurorehabilitation, Hopsital of Vipiteno-Sterzing, Vipiteno-Sterzing, Italy.,Research Unit for Neurorehabilitation of South Tyrol, Bolzano, Italy
| | - Kerstin Schwenker
- Department of Neurology, Christian Doppler Klinik, Paracelsus Medical University, Salzburg, Austria.,Karl Landsteiner Institut für Neurorehabilitation und Raumfahrtneurologie, Salzburg, Austria
| | - Patrick B Langthaler
- Department of Neurology, Christian Doppler Klinik, Paracelsus Medical University, Salzburg, Austria
| | - Stefan Golaszewski
- Department of Neurology, Christian Doppler Klinik, Paracelsus Medical University, Salzburg, Austria.,Karl Landsteiner Institut für Neurorehabilitation und Raumfahrtneurologie, Salzburg, Austria
| | - Luca Sebastianelli
- Department of Neurorehabilitation, Hopsital of Vipiteno-Sterzing, Vipiteno-Sterzing, Italy.,Research Unit for Neurorehabilitation of South Tyrol, Bolzano, Italy
| | - Francesco Brigo
- Department of Neurology, Franz Tappeiner Hospital, Merano, Italy.,Department of Neuroscience, Biomedicine and Movement Science, University of Verona, Verona, Italy
| | | | - Leopold Saltuari
- Research Unit for Neurorehabilitation of South Tyrol, Bolzano, Italy.,Department of Neurology, Hochzirl Hospital, Zirl, Austria
| | - Raffaele Nardone
- Department of Neurology, Christian Doppler Klinik, Paracelsus Medical University, Salzburg, Austria.,Karl Landsteiner Institut für Neurorehabilitation und Raumfahrtneurologie, Salzburg, Austria.,Department of Neurology, Franz Tappeiner Hospital, Merano, Italy
| |
Collapse
|
19
|
Bani-Ahmed AA. Post-stroke motor recovery and cortical organization following Constraint-Induced Movement Therapies: a literature review. J Phys Ther Sci 2019; 31:950-959. [PMID: 31871384 PMCID: PMC6879401 DOI: 10.1589/jpts.31.950] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2019] [Accepted: 08/07/2019] [Indexed: 11/24/2022] Open
Abstract
[Purpose] This review synthesizes findings from studies on two forms of Constraint-Induced Movement Therapies: the original Constraint-Induced Movement Therapy and the modified Constraint-Induced Movement Therapy, in adult stroke patients including the evidence, current limitations and future directions. [Methods] We critically reviewed studies evaluating the effectiveness of Constraint-Induced Movement Therapies in chronic stoke focusing on the functional (i.e. motor recovery) and the neural (i.e. cortical organization) levels. [Results] Constraint-Induced Movement Therapies seemed to improve the upper limb functional usage in chronic stoke with no reliable neurophysiological underlying mechanisms. The Motor Activity Log was the common outcome measuring motor recovery. The work that has been done on modified Constraint-Induced Movement Therapy was far less than the work done on the original Constraint-Induced Movement Therapy. [Conclusion] Evident lack of understanding of the association between changes in motor recovery and the underlying neural mechanisms in-terms of measures of assessing and defining functional recovery (i.e Motor Activity Log) that lacks sufficient sensitivity to characterize changes in movement strategies and thereby lack of distinction between recovery and behavioral compensation. Future studies should employ using kinematic metrics to quantify and explain the training-related changes in behavior following Constraint-Induced Movement Therapies in chronic stroke.
Collapse
Affiliation(s)
- Ali Ahmed Bani-Ahmed
- Department of Physical Therapy, Faculty of Applied Medical Sciences, University of Tabuk: 71491 Tabuk, KSA
| |
Collapse
|
20
|
Kusumaningsih W, Triangto K, Salim H. Gait turning patterns in chronic ischemic stroke males and its relationship to recovery: A cross-sectional study. Medicine (Baltimore) 2019; 98:e17210. [PMID: 31567973 PMCID: PMC6756695 DOI: 10.1097/md.0000000000017210] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/22/2019] [Revised: 08/19/2019] [Accepted: 08/23/2019] [Indexed: 11/26/2022] Open
Abstract
INTRODUCTION Impaired turning patterns have been considered as 1 factor which potentially leads to disability in chronic stroke patients. Mobility comprises 80% of the chief disability, and would eventually lead to falls. Expanded Timed Up and Go (ETUG) is an effective mobility assessment method. It utilizes video recording to analyze the conventional Time Up and Go (TUG) Test components, which includes turning pattern analysis. METHODS Six healthy males without stroke history and 21 chronic ischemic stroke males (divided into subjects with or without the presence of flexor synergy pattern subgroups) capable of independent ambulation were recruited from Neurology and Medical Rehabilitation Department outpatient clinic. ETUG tests were recorded for each subject and were analyzed thoroughly using a computer program. RESULTS Timed Up and Go time was significantly different between the 3 groups (P = .001). As compared to control, and synergy absent group, median turning time was highest in chronic stroke patients with presence of flexor synergy by 2786 ms (P = .002), but was not significantly different in percentage ETUG (14%, P = .939). Further analysis revealed that Brunnstrom stage and number of steps taken for turning significantly affect TUG duration. Other factors such as hemiparetic side, or body height were not significantly associated. DISCUSSION The presence of flexor synergy would significantly affect turning time, this would then correlate to the disability of shifting body's center of gravity, as a part of the Stroke core set of International Classification of Functioning, Disability, and Health (ICF).Therefore, stroke patients need to have early ambulatory training regarding pivoting motion rather than solely focusing on straight walking. Instead of hemiparetic side, it is possible that overall turning time is affected by coordination and orientation capability, signifying the importance of cortical plasticity.
Collapse
Affiliation(s)
- Widjajalaksmi Kusumaningsih
- Department of Physical Medicine and Rehabilitation Cipto Mangunkusumo Hospital
- Neuroscience and Brain Development Cluster, Indonesian Medical Education and Research Institute, Faculty of Medicine, University of Indonesia Jakarta
| | - Kevin Triangto
- Department of Physical Medicine and Rehabilitation Cipto Mangunkusumo Hospital
| | - Harris Salim
- Department of Neurology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia
| |
Collapse
|
21
|
Chen YC, Chou WH, Tsou HH, Fang CP, Liu TH, Tsao HH, Hsu WC, Weng YC, Wang Y, Liu YL. A Post-hoc Study of D-Amino Acid Oxidase in Blood as an Indicator of Post-stroke Dementia. Front Neurol 2019; 10:402. [PMID: 31105635 PMCID: PMC6497996 DOI: 10.3389/fneur.2019.00402] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2018] [Accepted: 04/03/2019] [Indexed: 02/03/2023] Open
Abstract
Stroke is an important risk factor for dementia. Epidemiological studies have indicated a high incidence of dementia in stroke patients. There is currently no effective biomarker for the diagnosis of post-stroke dementia (PSD). D-amino acid oxidase (DAO) is a flavin-dependent enzyme widely distributed in the central nervous system. DAO oxidizes D-amino acids, a process which generates neurotoxic hydrogen peroxide and leads to neurodegeneration. This study aimed to examine post-stroke plasma DAO levels as a biomarker for PSD. In total, 53 patients with PSD, 20 post-stroke patients without dementia (PSNoD), and 71 age- and gender-matched normal controls were recruited. Cognitive function was evaluated at more than 30 days post-stroke. Plasma DAO was measured using the enzyme-linked immunosorbent assay. White matter hyperintensity (WMH), a neuroimaging biomarker of cerebral small vessel diseases, was determined by magnetic resonance imaging. We found that plasma DAO levels were independently higher in PSD subjects than in PSNoD subjects or the controls and were correlated with the WMH load in stroke patients. Using an area under the curve (AUC)/receiver operating characteristic analysis, plasma DAO levels were significantly reliable for the diagnosis of PSD. The sensitivity and specificity of the optimal cut-off value of 321 ng/ml of plasma DAO for the diagnosis of PSD were 75 and 88.7%, respectively. In conclusion, our data support that plasma DAO levels were increased in PSD patients and correlated with brain WMH, independent of age, gender, hypertension, and renal function. Plasma DAO levels may therefore aid in PSD diagnosis.
Collapse
Affiliation(s)
- Yi-Chun Chen
- Department of Neurology, Chang Gung Memorial Hospital Linkou Medical Center and College of Medicine, Chang Gung University, Taoyuan, Taiwan.,Dementia Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan
| | - Wen-Hai Chou
- Center for Neuropsychiatric Research, National Health Research Institutes, Miaoli, Taiwan
| | - Hsiao-Hui Tsou
- Division of Biostatistics and Bioinformatics, Institute of Population Health Sciences, National Health Research Institutes, Miaoli, Taiwan.,Graduate Institute of Biostatistics, China Medical University, Taichung, Taiwan
| | - Chiu-Ping Fang
- Center for Neuropsychiatric Research, National Health Research Institutes, Miaoli, Taiwan
| | - Tung-Hsia Liu
- Center for Neuropsychiatric Research, National Health Research Institutes, Miaoli, Taiwan
| | - Hsien-Hao Tsao
- Department of Medicine, Chang Gung University, Taoyuan, Taiwan
| | - Wen-Chuin Hsu
- Department of Neurology, Chang Gung Memorial Hospital Linkou Medical Center and College of Medicine, Chang Gung University, Taoyuan, Taiwan.,Dementia Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan
| | - Yi-Chinn Weng
- Center for Neuropsychiatric Research, National Health Research Institutes, Miaoli, Taiwan
| | - Yun Wang
- Center for Neuropsychiatric Research, National Health Research Institutes, Miaoli, Taiwan
| | - Yu-Li Liu
- Center for Neuropsychiatric Research, National Health Research Institutes, Miaoli, Taiwan
| |
Collapse
|
22
|
Hypoxia tolerance in the Norrin-deficient retina and the chronically hypoxic brain studied at single-cell resolution. Proc Natl Acad Sci U S A 2019; 116:9103-9114. [PMID: 30988181 DOI: 10.1073/pnas.1821122116] [Citation(s) in RCA: 40] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023] Open
Abstract
The mammalian CNS is capable of tolerating chronic hypoxia, but cell type-specific responses to this stress have not been systematically characterized. In the Norrin KO (Ndp KO ) mouse, a model of familial exudative vitreoretinopathy (FEVR), developmental hypovascularization of the retina produces chronic hypoxia of inner nuclear-layer (INL) neurons and Muller glia. We used single-cell RNA sequencing, untargeted metabolomics, and metabolite labeling from 13C-glucose to compare WT and Ndp KO retinas. In Ndp KO retinas, we observe gene expression responses consistent with hypoxia in Muller glia and retinal neurons, and we find a metabolic shift that combines reduced flux through the TCA cycle with increased synthesis of serine, glycine, and glutathione. We also used single-cell RNA sequencing to compare the responses of individual cell types in Ndp KO retinas with those in the hypoxic cerebral cortex of mice that were housed for 1 week in a reduced oxygen environment (7.5% oxygen). In the hypoxic cerebral cortex, glial transcriptome responses most closely resemble the response of Muller glia in the Ndp KO retina. In both retina and brain, vascular endothelial cells activate a previously dormant tip cell gene expression program, which likely underlies the adaptive neoangiogenic response to chronic hypoxia. These analyses of retina and brain transcriptomes at single-cell resolution reveal both shared and cell type-specific changes in gene expression in response to chronic hypoxia, implying both shared and distinct cell type-specific physiologic responses.
Collapse
|
23
|
Mu J, Bakreen A, Juntunen M, Korhonen P, Oinonen E, Cui L, Myllyniemi M, Zhao S, Miettinen S, Jolkkonen J. Combined Adipose Tissue-Derived Mesenchymal Stem Cell Therapy and Rehabilitation in Experimental Stroke. Front Neurol 2019; 10:235. [PMID: 30972000 PMCID: PMC6443824 DOI: 10.3389/fneur.2019.00235] [Citation(s) in RCA: 35] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2018] [Accepted: 02/22/2019] [Indexed: 01/12/2023] Open
Abstract
Background/Objective: Stroke is a leading global cause of adult disability. As the population ages as well as suffers co-morbidities, it is expected that the stroke burden will increase further. There are no established safe and effective restorative treatments to facilitate a good functional outcome in stroke patients. Cell-based therapies, which have a wide therapeutic window, might benefit a large percentage of patients, especially if combined with different restorative strategies. In this study, we tested whether the therapeutic effect of human adipose tissue-derived mesenchymal stem cells (ADMSCs) could be further enhanced by rehabilitation in an experimental model of stroke. Methods: Focal cerebral ischemia was induced in adult male Sprague Dawley rats by permanently occluding the distal middle cerebral artery (MCAO). After the intravenous infusion of vehicle (n = 46) or ADMSCs (2 × 106) either at 2 (n = 37) or 7 (n = 7) days after the operation, half of the animals were housed in an enriched environment mimicking rehabilitation. Subsequently, their behavioral recovery was assessed by a neurological score, and performance in the cylinder and sticky label tests during a 42-day behavioral follow-up. At the end of the follow-up, rats were perfused for histology to assess the extent of angiogenesis (RECA-1), gliosis (GFAP), and glial scar formation. Results: No adverse effects were observed during the follow-up. Combined ADMSC therapy and rehabilitation improved forelimb use in the cylinder test in comparison to MCAO controls on post-operative days 21 and 42 (P < 0.01). In the sticky label test, ADMSCs and rehabilitation alone or together, significantly decreased the removal time as compared to MCAO controls on post-operative days 21 and 42. An early initiation of combined therapy seemed to be more effective. Infarct size, measured by MRI on post-operative days 1 and 43, did not differ between the experimental groups. Stereological counting revealed an ischemia-induced increase both in the density of blood vessels and the numbers of glial cells in the perilesional cortex, but there were no differences among MCAO groups. Glial scar volume was also similar in MCAO groups. Conclusion: Early delivery of ADMSCs and combined rehabilitation enhanced behavioral recovery in an experimental stroke model. The mechanisms underlying these treatment effects remain unknown.
Collapse
Affiliation(s)
- Jingwei Mu
- Department of Neurology, The People's Hospital of China Medical University, Shenyang, China.,Department of Neurology, University of Eastern Finland, Kuopio, Finland
| | | | - Miia Juntunen
- Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.,Research, Development and Innovation Centre, Tampere University Hospital, Tampere, Finland
| | - Paula Korhonen
- A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland
| | - Ella Oinonen
- Department of Neurology, University of Eastern Finland, Kuopio, Finland
| | - Lili Cui
- Department of Neurology, University of Eastern Finland, Kuopio, Finland
| | - Mikko Myllyniemi
- Department of Neurology, University of Eastern Finland, Kuopio, Finland
| | - Shanshan Zhao
- Department of Neurology, University of Eastern Finland, Kuopio, Finland
| | - Susanna Miettinen
- Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.,Research, Development and Innovation Centre, Tampere University Hospital, Tampere, Finland
| | - Jukka Jolkkonen
- Department of Neurology, University of Eastern Finland, Kuopio, Finland.,A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.,Neurocenter, Kuopio University Hospital, Kuopio, Finland
| |
Collapse
|
24
|
Neumann K, Euler HA, Kob M, Wolff von Gudenberg A, Giraud AL, Weissgerber T, Kell CA. Assisted and unassisted recession of functional anomalies associated with dysprosody in adults who stutter. JOURNAL OF FLUENCY DISORDERS 2018; 55:120-134. [PMID: 28958627 DOI: 10.1016/j.jfludis.2017.09.003] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/26/2016] [Revised: 09/04/2017] [Accepted: 09/05/2017] [Indexed: 06/07/2023]
Abstract
PURPOSE Speech in persons who stutter (PWS) is associated with disturbed prosody (speech melody and intonation), which may impact communication. The neural correlates of PWS' altered prosody during speaking are not known, neither is how a speech-restructuring therapy affects prosody at both a behavioral and a cerebral level. METHODS In this fMRI study, we explored group differences in brain activation associated with the production of different kinds of prosody in 13 male adults who stutter (AWS) before, directly after, and at least 1 year after an effective intensive fluency-shaping treatment, in 13 typically fluent-speaking control participants (CP), and in 13 males who had spontaneously recovered from stuttering during adulthood (RAWS), while sentences were read aloud with 'neutral', instructed emotional (happy), and linguistically driven (questioning) prosody. These activations were related to speech production acoustics. RESULTS During pre-treatment prosody generation, the pars orbitalis of the left inferior frontal gyrus and the left anterior insula were activated less in AWS than in CP. The degree of hypo-activation correlated with acoustic measures of dysprosody. Paralleling the near-normalization of free speech melody following fluency-shaping therapy, AWS normalized the inferior frontal hypo-activation, sooner after treatment for generating emotional than linguistic prosody. Unassisted recovery was associated with an additional recruitment of cerebellar resources. CONCLUSIONS Fluency shaping therapy may restructure prosody, which approaches that of typically fluent-speaking people. Such a process may benefit from additional training of instructed emotional and linguistic prosody by inducing plasticity in the inferior frontal region which has developed abnormally during childhood in PWS.
Collapse
Affiliation(s)
- Katrin Neumann
- Department of Phoniatrics and Pediatric Audiology, Clinic of Otorhinolaryngology, Head and Neck Surgery,St. Elisabeth-Hospital, Ruhr University Bochum, Bochum, Germany.
| | - Harald A Euler
- Department of Phoniatrics and Pediatric Audiology, Clinic of Otorhinolaryngology, Head and Neck Surgery,St. Elisabeth-Hospital, Ruhr University Bochum, Bochum, Germany
| | - Malte Kob
- Erich-Thienhaus-Institute, University of Music Detmold, Detmold, Germany
| | | | - Anne-Lise Giraud
- Département des Neuroscience Fondamentales, Université de Genève, Switzerland
| | - Tobias Weissgerber
- Department of Audiological Acoustics, Clinic of Otorhinolaryngology, Goethe University Frankfurt, Frankfurt am Main, Germany
| | - Christian A Kell
- Brain Imaging Center and Department of Neurology, Goethe University Frankfurt, Frankfurt am Main, Germany
| |
Collapse
|
25
|
Israely S, Leisman G, Machluf CC, Carmeli E. Muscle Synergies Control during Hand-Reaching Tasks in Multiple Directions Post-stroke. Front Comput Neurosci 2018. [PMID: 29527159 PMCID: PMC5829096 DOI: 10.3389/fncom.2018.00010] [Citation(s) in RCA: 25] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023] Open
Abstract
Purpose: A muscle synergies model was suggested to represent a simplifying motor control mechanism by the brainstem and spinal cord. The aim of the study was to investigate the feasibility of such control mechanisms in the rehabilitation of post-stroke individuals during the execution of hand-reaching movements in multiple directions, compared to non-stroke individuals. Methods: Twelve non-stroke and 13 post-stroke individuals participated in the study. Muscle synergies were extracted from EMG data that was recorded during hand reaching tasks, using the NMF algorithm. The optimal number of synergies was evaluated in both groups using the Variance Accounted For (VAF) and the Mean Squared Error (MSE). A cross validation procedure was carried out to define a representative set of synergies. The similarity index and the K-means algorithm were applied to validate the existence of such a set of synergies, but also to compare the modulation properties of synergies for different movement directions between groups. The similarity index and hierarchical cluster analysis were also applied to compare between group synergies. Results: Four synergies were chosen to optimally capture the variances in the EMG data, with mean VAF of 0.917 ± 0.034 and 0.883 ± 0.046 of the data variances, with respective MSE of 0.007 and 0.016, in the control and study groups, respectively. The representative set of synergies was set to be extracted from movement to the center of the reaching space. Two synergies had different muscle activation balance between groups. Seven and 17 clusters partitioned the muscle synergies of the control and study groups. The control group exhibited a gradual change in the activation in the amplitude in the time domain (modulation) of synergies, as reflected by the similarity index, whereas the study group exhibited consistently significant differences between all movement directions and the representative set of synergies. The study findings support the existence of a representative set of synergies, which are modulated to execute movements in different directions. Conclusions: Post-stroke individuals differently modulate the activation of synergies to different movement directions than do non-stroke individuals. The conclusion was supported by different muscle activation balances, similarity values and different classifications of synergies among groups.
Collapse
Affiliation(s)
- Sharon Israely
- Department of Physical Therapy, University of Haifa, Haifa, Israel
| | - Gerry Leisman
- Department of Physical Therapy, University of Haifa, Haifa, Israel.,National Institute for Brain & Rehabilitation Sciences-Israel, Nazareth, Israel
| | - Chay C Machluf
- Signal and Image Laboratory, Faculty of Electrical Engineering, Technion - Israel Institute of Technology, Haifa, Israel
| | - Eli Carmeli
- Department of Physical Therapy, University of Haifa, Haifa, Israel
| |
Collapse
|
26
|
Iglesias-Rey R, Rodríguez-Yáñez M, Rodríguez-Castro E, Pumar JM, Arias S, Santamaría M, López-Dequidt I, Hervella P, Correa-Paz C, Sobrino T, Vivien D, Campos F, Castellanos M, Castillo J. Worse Outcome in Stroke Patients Treated with rt-PA Without Early Reperfusion: Associated Factors. Transl Stroke Res 2017; 9:347-355. [PMID: 29116527 PMCID: PMC6061244 DOI: 10.1007/s12975-017-0584-9] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2017] [Revised: 10/23/2017] [Accepted: 10/30/2017] [Indexed: 02/07/2023]
Abstract
Based on preclinical studies suggesting that recombinant tissue plasminogen activator (rt-PA) may promote ischemic brain injuries, we investigated in patients the possible risk of worse clinical outcome after rt-PA treatment as a result of its inability to resolve cerebral ischemia. Here, we designed a cohort study using a retrospective analysis of patients who received treatment with intravenous (4.5-h window) or intraarterial rt-PA, without or with thrombectomy. Controls were consecutive patients who did not receive recanalization treatment, who met all inclusion criteria. As a marker of reperfusion, we defined the variable of early neurological improvement as the difference between the score of the National Institute of Health Stroke Scale (NIHSS) (at admission and 24 h). The main variable was worsening of the patient’s functional situation in the first 3 months. To compare quantitative variables, we used Student’s t test or the Mann-Whitney test. To estimate the odds ratios of each independent variable in the patient’s worsening in the first 3 months, we used a logistic regression model. We included 1154 patients; 577 received rt-PA, and 577 served as controls. In the group of patients treated with rt-PA, 39.4% who did not present clinical reperfusion data developed worsening within 3 months after stroke compared with 3.5% of patients with reperfusion (P < 0.0001). These differences were not significant in the control group. In summary, administration of rt-PA intravenously or intraarterially without reperfusion within the first 24 h may be associated with a higher risk of functional deterioration in the first 3 months.
Collapse
Affiliation(s)
- Ramón Iglesias-Rey
- Clinical Neurosciences Research Laboratory, Department of Neurology, Clinical University Hospital, Universidade de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), 15706, Santiago de Compostela, Spain.
| | - Manuel Rodríguez-Yáñez
- Clinical Neurosciences Research Laboratory, Department of Neurology, Clinical University Hospital, Universidade de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), 15706, Santiago de Compostela, Spain
| | - Emilio Rodríguez-Castro
- Clinical Neurosciences Research Laboratory, Department of Neurology, Clinical University Hospital, Universidade de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), 15706, Santiago de Compostela, Spain
| | - José Manuel Pumar
- Department of Neuroradiology, Clinical University Hospital, Universidade de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), 15706, Santiago de Compostela, Spain
| | - Susana Arias
- Clinical Neurosciences Research Laboratory, Department of Neurology, Clinical University Hospital, Universidade de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), 15706, Santiago de Compostela, Spain
| | - María Santamaría
- Clinical Neurosciences Research Laboratory, Department of Neurology, Clinical University Hospital, Universidade de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), 15706, Santiago de Compostela, Spain
| | - Iria López-Dequidt
- Clinical Neurosciences Research Laboratory, Department of Neurology, Clinical University Hospital, Universidade de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), 15706, Santiago de Compostela, Spain
| | - Pablo Hervella
- Clinical Neurosciences Research Laboratory, Department of Neurology, Clinical University Hospital, Universidade de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), 15706, Santiago de Compostela, Spain
| | - Clara Correa-Paz
- Clinical Neurosciences Research Laboratory, Department of Neurology, Clinical University Hospital, Universidade de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), 15706, Santiago de Compostela, Spain
| | - Tomás Sobrino
- Clinical Neurosciences Research Laboratory, Department of Neurology, Clinical University Hospital, Universidade de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), 15706, Santiago de Compostela, Spain
| | - Denis Vivien
- Inserm, Inserm, UMR-S U1237, Physiopathology and Imaging of Neurological diseases, GIP Cyceron, Caen Normandie University, 14073, Caen, France
- CHU de Caen, Department of Clinical Research, Caen University Hospital, 14000, Caen, France
| | - Francisco Campos
- Clinical Neurosciences Research Laboratory, Department of Neurology, Clinical University Hospital, Universidade de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), 15706, Santiago de Compostela, Spain
| | - Mar Castellanos
- Department of Neurology, Biomedical Research Institute, University Hospital A Coruña, 15006, Corunna, Spain
| | - José Castillo
- Clinical Neurosciences Research Laboratory, Department of Neurology, Clinical University Hospital, Universidade de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), 15706, Santiago de Compostela, Spain
| |
Collapse
|
27
|
Granbichler CA, Oberaigner W, Kuchukhidze G, Ndayisaba JP, Ndayisaba A, Taylor A, Bauer G, Luef G, Trinka E. Decrease in mortality of adult epilepsy patients since 1980: lessons learned from a hospital-based cohort. Eur J Neurol 2017; 24:667-672. [PMID: 28239917 DOI: 10.1111/ene.13267] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2016] [Revised: 10/29/2016] [Accepted: 11/14/2016] [Indexed: 01/09/2023]
Abstract
BACKGROUND AND PURPOSE Data on mortality in patients with epilepsy have been available since the 1800s. They consistently show a 2-3-fold increase compared to the general population. Despite major advances in diagnostic tools and treatment options, there is no evidence for a decrease in premature deaths. The temporal trend of mortality in a hospital-based epilepsy cohort over three decades was assessed. METHODS A hospital-based incidence cohort was recruited from a specialized epilepsy outpatient clinic at Innsbruck Medical University between 1980 and 2007, divided by decade into three cohorts and followed for 5 years after initial epilepsy diagnosis. Deaths and their primary causes were determined using probabilistic record linkage with the Austrian death registry. Age-, sex- and period-adjusted standardized mortality rates (SMRs) were computed in relation to the general population of the same area and grouped according to time of diagnosis. RESULTS In all, 122 deaths in 4549.9 person-years (1954.5 women, 2595.2 men) were identified. The overall SMR was 2.2 [95% confidence interval (CI) 1.8-2.6] and decreased from 3.0 (95% CI 2.1-4.3) in 1980-1989, to 2.7 (95% CI 2.0-3.5) in 1990-1999 and to 1.4 (95% CI 1.0-2.0) in 2000-2007. CONCLUSIONS This study indicates a decrease in mortality in newly diagnosed epilepsy patients over the last three decades. This may be due to advances in diagnosis and treatment over the past three decades, including early identification of drug resistance, introduction of new anti-epileptic drugs and establishment of a comprehensive epilepsy surgery programme in this region.
Collapse
Affiliation(s)
- C A Granbichler
- Department of Neurology, Christian Doppler Klinik, Paracelsus Medical University, Salzburg, Austria.,Department of Neurology, Medical University Innsbruck, Innsbruck, Austria
| | - W Oberaigner
- Institute for Clinical Epidemiology, TILAK, Innsbruck, Austria.,Department of Public Health and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria
| | - G Kuchukhidze
- Department of Neurology, Christian Doppler Klinik, Paracelsus Medical University, Salzburg, Austria.,Department of Neurology, Medical University Innsbruck, Innsbruck, Austria
| | - J-P Ndayisaba
- Department of Neurology, Christian Doppler Klinik, Paracelsus Medical University, Salzburg, Austria
| | - A Ndayisaba
- Department of Neurology, Christian Doppler Klinik, Paracelsus Medical University, Salzburg, Austria
| | - A Taylor
- Department of Neurology, Medical University Innsbruck, Innsbruck, Austria
| | - G Bauer
- Department of Neurology, Christian Doppler Klinik, Paracelsus Medical University, Salzburg, Austria
| | - G Luef
- Department of Neurology, Christian Doppler Klinik, Paracelsus Medical University, Salzburg, Austria
| | - E Trinka
- Department of Neurology, Christian Doppler Klinik, Paracelsus Medical University, Salzburg, Austria.,Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.,Department of Public Health and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria
| |
Collapse
|
28
|
Delavaran H, Aked J, Sjunnesson H, Lindvall O, Norrving B, Kokaia Z, Lindgren A. Spontaneous Recovery of Upper Extremity Motor Impairment After Ischemic Stroke: Implications for Stem Cell-Based Therapeutic Approaches. Transl Stroke Res 2017; 8:351-361. [PMID: 28205065 PMCID: PMC5493719 DOI: 10.1007/s12975-017-0523-9] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2016] [Accepted: 01/29/2017] [Indexed: 01/18/2023]
Abstract
Preclinical studies suggest that stem cell therapy (SCT) may improve sensorimotor recovery after stroke. Upper extremity motor impairment (UEMI) is common after stroke, often entailing substantial disability. To evaluate the feasibility of post-stroke UEMI as a target for SCT, we examined a selected sample of stroke patients potentially suitable for SCT, aiming to assess the frequency and recovery of UEMI, as well as its relation to activity limitations and participation restrictions. Patients aged 20–75 years with first-ever ischemic stroke, and National Institutes of Health Stroke Scale (NIHSS) scores 1–18, underwent brain diffusion-weighted MRI within 4 days of stroke onset (n = 108). Survivors were followed up after 3–5 years, including assessment with NIHSS, Fugl-Meyer assessment of upper extremity (FMA-UE), modified Rankin Scale (mRS), and Stroke Impact Scale (SIS). UEMI was defined as NIHSS arm/hand score ≥1. UEMI recovery was evaluated with change in NIHSS arm/hand scores between baseline and follow-up. Of 97 survivors, 84 were available to follow-up. Among 76 subjects (of 84) without recurrent stroke, 41 had UEMI at baseline of which 10 had residual UEMI at follow-up. The FMA-UE showed moderate-severe impairment in seven of 10 survivors with residual UEMI. UEMI was correlated to mRS (rs = 0.49, p < 0.001) and the SIS social participation domain (rs = −0.38, p = 0.001). Nearly 25% of the subjects with UEMI at baseline had residual impairment after 3–5 years, whereas about 75% showed complete recovery. Most of the subjects with residual UEMI had moderate-severe impairment, which correlated strongly to dependency in daily activities and social participation restrictions. Our findings suggest that SCT targeting post-stroke UEMI may be clinically valuable with significant meaningful benefits for patients but also emphasize the need of early prognostication to detect patients that will have residual impairment in order to optimize patient selection for SCT.
Collapse
Affiliation(s)
- Hossein Delavaran
- Department of Clinical Sciences Lund, Division of Neurology, Lund University, Lund, Sweden.
- Department of Neurology and Rehabilitation Medicine, Skåne University Hospital, Lund, Sweden.
| | - Joseph Aked
- Department of Clinical Sciences Lund, Division of Neurology, Lund University, Lund, Sweden
| | - Håkan Sjunnesson
- Center for Medical Imaging and Physiology, Skåne University Hospital, Lund, Sweden
| | - Olle Lindvall
- Department of Clinical Sciences Lund, Division of Neurology, Lund University, Lund, Sweden
- Department of Neurology and Rehabilitation Medicine, Skåne University Hospital, Lund, Sweden
- Laboratory of Stem Cells and Restorative Neurology, Lund Stem Cell Center, Lund University, Lund, Sweden
| | - Bo Norrving
- Department of Clinical Sciences Lund, Division of Neurology, Lund University, Lund, Sweden
- Department of Neurology and Rehabilitation Medicine, Skåne University Hospital, Lund, Sweden
| | - Zaal Kokaia
- Department of Clinical Sciences Lund, Division of Neurology, Lund University, Lund, Sweden
- Laboratory of Stem Cells and Restorative Neurology, Lund Stem Cell Center, Lund University, Lund, Sweden
| | - Arne Lindgren
- Department of Clinical Sciences Lund, Division of Neurology, Lund University, Lund, Sweden
- Department of Neurology and Rehabilitation Medicine, Skåne University Hospital, Lund, Sweden
| |
Collapse
|
29
|
Cramer SC, Wolf SL, Adams HP, Chen D, Dromerick AW, Dunning K, Ellerbe C, Grande A, Janis S, Lansberg MG, Lazar RM, Palesch YY, Richards L, Roth E, Savitz SI, Wechsler LR, Wintermark M, Broderick JP. Stroke Recovery and Rehabilitation Research: Issues, Opportunities, and the National Institutes of Health StrokeNet. Stroke 2017; 48:813-819. [PMID: 28174324 DOI: 10.1161/strokeaha.116.015501] [Citation(s) in RCA: 80] [Impact Index Per Article: 11.4] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2016] [Revised: 12/14/2016] [Accepted: 01/05/2017] [Indexed: 12/15/2022]
Affiliation(s)
- Steven C Cramer
- From the Departments of Neurology, Anatomy and Neurobiology (S.C.C.), and Physical Medicine and Rehabilitation (S.C.C.), and the Sue and Bill Gross Stem Cell Research Center (S.C.C.), University of California, Irvine; Division of Physical Therapy, Department of Rehabilitation Medicine, Emory University School of Medicine, Atlanta, GA (S.L.W.); Atlanta VA Center for Visual and Neurocognitive Rehabilitation, GA (S.L.W.); Department of Neurology, University of Iowa, Iowa City (H.P.A.); Extramural Research Program, National Institute of Neurological Disorders and Stroke, Bethesda, MD (D.C.); Department of Rehabilitation Medicine, MedStar National Rehabilitation Hospital, Georgetown University, Washington, DC (A.W.D.); Washington DC VA Medical Center (A.W.D.); Department of Rehabilitation Sciences, University of Cincinnati, OH (K.D.); Data Coordination Unit, Department of Public Health Sciences, Medical University of South Carolina, Charleston (C.E., Y.Y.P.); Department of Neurosurgery, University of Minnesota, Minneapolis (A.G.); Office of Clinical Research, National Institute of Neurological Disorders and Stroke, Bethesda, MD (S.J.); Department of Neurology and Neurological Sciences, Stanford Stroke Center, Stanford University School of Medicine, CA (M.G.L.); Stroke Division, Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY (R.M.L.); Department of Occupational Therapy, University of Utah, Salt Lake City (L.R.); Department of Physical Medicine and Rehabilitation, Northwestern Feinberg School of Medicine, Chicago, IL (E.R.); Department of Neurology, University of Texas, Houston (S.I.S.); Department of Neurology, University of Pittsburgh Medical School, PA (L.R.W.); Neuroradiology Section, Department of Radiology, Stanford Healthcare and School of Medicine, CA (M.W.); University of Cincinnati Gardner Neuroscience Institute (J.P.B.) and Department of Neurology and Rehabilitation Medicine (J.P.B.), University of Cincinnati, OH.
| | - Steven L Wolf
- From the Departments of Neurology, Anatomy and Neurobiology (S.C.C.), and Physical Medicine and Rehabilitation (S.C.C.), and the Sue and Bill Gross Stem Cell Research Center (S.C.C.), University of California, Irvine; Division of Physical Therapy, Department of Rehabilitation Medicine, Emory University School of Medicine, Atlanta, GA (S.L.W.); Atlanta VA Center for Visual and Neurocognitive Rehabilitation, GA (S.L.W.); Department of Neurology, University of Iowa, Iowa City (H.P.A.); Extramural Research Program, National Institute of Neurological Disorders and Stroke, Bethesda, MD (D.C.); Department of Rehabilitation Medicine, MedStar National Rehabilitation Hospital, Georgetown University, Washington, DC (A.W.D.); Washington DC VA Medical Center (A.W.D.); Department of Rehabilitation Sciences, University of Cincinnati, OH (K.D.); Data Coordination Unit, Department of Public Health Sciences, Medical University of South Carolina, Charleston (C.E., Y.Y.P.); Department of Neurosurgery, University of Minnesota, Minneapolis (A.G.); Office of Clinical Research, National Institute of Neurological Disorders and Stroke, Bethesda, MD (S.J.); Department of Neurology and Neurological Sciences, Stanford Stroke Center, Stanford University School of Medicine, CA (M.G.L.); Stroke Division, Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY (R.M.L.); Department of Occupational Therapy, University of Utah, Salt Lake City (L.R.); Department of Physical Medicine and Rehabilitation, Northwestern Feinberg School of Medicine, Chicago, IL (E.R.); Department of Neurology, University of Texas, Houston (S.I.S.); Department of Neurology, University of Pittsburgh Medical School, PA (L.R.W.); Neuroradiology Section, Department of Radiology, Stanford Healthcare and School of Medicine, CA (M.W.); University of Cincinnati Gardner Neuroscience Institute (J.P.B.) and Department of Neurology and Rehabilitation Medicine (J.P.B.), University of Cincinnati, OH
| | - Harold P Adams
- From the Departments of Neurology, Anatomy and Neurobiology (S.C.C.), and Physical Medicine and Rehabilitation (S.C.C.), and the Sue and Bill Gross Stem Cell Research Center (S.C.C.), University of California, Irvine; Division of Physical Therapy, Department of Rehabilitation Medicine, Emory University School of Medicine, Atlanta, GA (S.L.W.); Atlanta VA Center for Visual and Neurocognitive Rehabilitation, GA (S.L.W.); Department of Neurology, University of Iowa, Iowa City (H.P.A.); Extramural Research Program, National Institute of Neurological Disorders and Stroke, Bethesda, MD (D.C.); Department of Rehabilitation Medicine, MedStar National Rehabilitation Hospital, Georgetown University, Washington, DC (A.W.D.); Washington DC VA Medical Center (A.W.D.); Department of Rehabilitation Sciences, University of Cincinnati, OH (K.D.); Data Coordination Unit, Department of Public Health Sciences, Medical University of South Carolina, Charleston (C.E., Y.Y.P.); Department of Neurosurgery, University of Minnesota, Minneapolis (A.G.); Office of Clinical Research, National Institute of Neurological Disorders and Stroke, Bethesda, MD (S.J.); Department of Neurology and Neurological Sciences, Stanford Stroke Center, Stanford University School of Medicine, CA (M.G.L.); Stroke Division, Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY (R.M.L.); Department of Occupational Therapy, University of Utah, Salt Lake City (L.R.); Department of Physical Medicine and Rehabilitation, Northwestern Feinberg School of Medicine, Chicago, IL (E.R.); Department of Neurology, University of Texas, Houston (S.I.S.); Department of Neurology, University of Pittsburgh Medical School, PA (L.R.W.); Neuroradiology Section, Department of Radiology, Stanford Healthcare and School of Medicine, CA (M.W.); University of Cincinnati Gardner Neuroscience Institute (J.P.B.) and Department of Neurology and Rehabilitation Medicine (J.P.B.), University of Cincinnati, OH
| | - Daofen Chen
- From the Departments of Neurology, Anatomy and Neurobiology (S.C.C.), and Physical Medicine and Rehabilitation (S.C.C.), and the Sue and Bill Gross Stem Cell Research Center (S.C.C.), University of California, Irvine; Division of Physical Therapy, Department of Rehabilitation Medicine, Emory University School of Medicine, Atlanta, GA (S.L.W.); Atlanta VA Center for Visual and Neurocognitive Rehabilitation, GA (S.L.W.); Department of Neurology, University of Iowa, Iowa City (H.P.A.); Extramural Research Program, National Institute of Neurological Disorders and Stroke, Bethesda, MD (D.C.); Department of Rehabilitation Medicine, MedStar National Rehabilitation Hospital, Georgetown University, Washington, DC (A.W.D.); Washington DC VA Medical Center (A.W.D.); Department of Rehabilitation Sciences, University of Cincinnati, OH (K.D.); Data Coordination Unit, Department of Public Health Sciences, Medical University of South Carolina, Charleston (C.E., Y.Y.P.); Department of Neurosurgery, University of Minnesota, Minneapolis (A.G.); Office of Clinical Research, National Institute of Neurological Disorders and Stroke, Bethesda, MD (S.J.); Department of Neurology and Neurological Sciences, Stanford Stroke Center, Stanford University School of Medicine, CA (M.G.L.); Stroke Division, Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY (R.M.L.); Department of Occupational Therapy, University of Utah, Salt Lake City (L.R.); Department of Physical Medicine and Rehabilitation, Northwestern Feinberg School of Medicine, Chicago, IL (E.R.); Department of Neurology, University of Texas, Houston (S.I.S.); Department of Neurology, University of Pittsburgh Medical School, PA (L.R.W.); Neuroradiology Section, Department of Radiology, Stanford Healthcare and School of Medicine, CA (M.W.); University of Cincinnati Gardner Neuroscience Institute (J.P.B.) and Department of Neurology and Rehabilitation Medicine (J.P.B.), University of Cincinnati, OH
| | - Alexander W Dromerick
- From the Departments of Neurology, Anatomy and Neurobiology (S.C.C.), and Physical Medicine and Rehabilitation (S.C.C.), and the Sue and Bill Gross Stem Cell Research Center (S.C.C.), University of California, Irvine; Division of Physical Therapy, Department of Rehabilitation Medicine, Emory University School of Medicine, Atlanta, GA (S.L.W.); Atlanta VA Center for Visual and Neurocognitive Rehabilitation, GA (S.L.W.); Department of Neurology, University of Iowa, Iowa City (H.P.A.); Extramural Research Program, National Institute of Neurological Disorders and Stroke, Bethesda, MD (D.C.); Department of Rehabilitation Medicine, MedStar National Rehabilitation Hospital, Georgetown University, Washington, DC (A.W.D.); Washington DC VA Medical Center (A.W.D.); Department of Rehabilitation Sciences, University of Cincinnati, OH (K.D.); Data Coordination Unit, Department of Public Health Sciences, Medical University of South Carolina, Charleston (C.E., Y.Y.P.); Department of Neurosurgery, University of Minnesota, Minneapolis (A.G.); Office of Clinical Research, National Institute of Neurological Disorders and Stroke, Bethesda, MD (S.J.); Department of Neurology and Neurological Sciences, Stanford Stroke Center, Stanford University School of Medicine, CA (M.G.L.); Stroke Division, Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY (R.M.L.); Department of Occupational Therapy, University of Utah, Salt Lake City (L.R.); Department of Physical Medicine and Rehabilitation, Northwestern Feinberg School of Medicine, Chicago, IL (E.R.); Department of Neurology, University of Texas, Houston (S.I.S.); Department of Neurology, University of Pittsburgh Medical School, PA (L.R.W.); Neuroradiology Section, Department of Radiology, Stanford Healthcare and School of Medicine, CA (M.W.); University of Cincinnati Gardner Neuroscience Institute (J.P.B.) and Department of Neurology and Rehabilitation Medicine (J.P.B.), University of Cincinnati, OH
| | - Kari Dunning
- From the Departments of Neurology, Anatomy and Neurobiology (S.C.C.), and Physical Medicine and Rehabilitation (S.C.C.), and the Sue and Bill Gross Stem Cell Research Center (S.C.C.), University of California, Irvine; Division of Physical Therapy, Department of Rehabilitation Medicine, Emory University School of Medicine, Atlanta, GA (S.L.W.); Atlanta VA Center for Visual and Neurocognitive Rehabilitation, GA (S.L.W.); Department of Neurology, University of Iowa, Iowa City (H.P.A.); Extramural Research Program, National Institute of Neurological Disorders and Stroke, Bethesda, MD (D.C.); Department of Rehabilitation Medicine, MedStar National Rehabilitation Hospital, Georgetown University, Washington, DC (A.W.D.); Washington DC VA Medical Center (A.W.D.); Department of Rehabilitation Sciences, University of Cincinnati, OH (K.D.); Data Coordination Unit, Department of Public Health Sciences, Medical University of South Carolina, Charleston (C.E., Y.Y.P.); Department of Neurosurgery, University of Minnesota, Minneapolis (A.G.); Office of Clinical Research, National Institute of Neurological Disorders and Stroke, Bethesda, MD (S.J.); Department of Neurology and Neurological Sciences, Stanford Stroke Center, Stanford University School of Medicine, CA (M.G.L.); Stroke Division, Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY (R.M.L.); Department of Occupational Therapy, University of Utah, Salt Lake City (L.R.); Department of Physical Medicine and Rehabilitation, Northwestern Feinberg School of Medicine, Chicago, IL (E.R.); Department of Neurology, University of Texas, Houston (S.I.S.); Department of Neurology, University of Pittsburgh Medical School, PA (L.R.W.); Neuroradiology Section, Department of Radiology, Stanford Healthcare and School of Medicine, CA (M.W.); University of Cincinnati Gardner Neuroscience Institute (J.P.B.) and Department of Neurology and Rehabilitation Medicine (J.P.B.), University of Cincinnati, OH
| | - Caitlyn Ellerbe
- From the Departments of Neurology, Anatomy and Neurobiology (S.C.C.), and Physical Medicine and Rehabilitation (S.C.C.), and the Sue and Bill Gross Stem Cell Research Center (S.C.C.), University of California, Irvine; Division of Physical Therapy, Department of Rehabilitation Medicine, Emory University School of Medicine, Atlanta, GA (S.L.W.); Atlanta VA Center for Visual and Neurocognitive Rehabilitation, GA (S.L.W.); Department of Neurology, University of Iowa, Iowa City (H.P.A.); Extramural Research Program, National Institute of Neurological Disorders and Stroke, Bethesda, MD (D.C.); Department of Rehabilitation Medicine, MedStar National Rehabilitation Hospital, Georgetown University, Washington, DC (A.W.D.); Washington DC VA Medical Center (A.W.D.); Department of Rehabilitation Sciences, University of Cincinnati, OH (K.D.); Data Coordination Unit, Department of Public Health Sciences, Medical University of South Carolina, Charleston (C.E., Y.Y.P.); Department of Neurosurgery, University of Minnesota, Minneapolis (A.G.); Office of Clinical Research, National Institute of Neurological Disorders and Stroke, Bethesda, MD (S.J.); Department of Neurology and Neurological Sciences, Stanford Stroke Center, Stanford University School of Medicine, CA (M.G.L.); Stroke Division, Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY (R.M.L.); Department of Occupational Therapy, University of Utah, Salt Lake City (L.R.); Department of Physical Medicine and Rehabilitation, Northwestern Feinberg School of Medicine, Chicago, IL (E.R.); Department of Neurology, University of Texas, Houston (S.I.S.); Department of Neurology, University of Pittsburgh Medical School, PA (L.R.W.); Neuroradiology Section, Department of Radiology, Stanford Healthcare and School of Medicine, CA (M.W.); University of Cincinnati Gardner Neuroscience Institute (J.P.B.) and Department of Neurology and Rehabilitation Medicine (J.P.B.), University of Cincinnati, OH
| | - Andrew Grande
- From the Departments of Neurology, Anatomy and Neurobiology (S.C.C.), and Physical Medicine and Rehabilitation (S.C.C.), and the Sue and Bill Gross Stem Cell Research Center (S.C.C.), University of California, Irvine; Division of Physical Therapy, Department of Rehabilitation Medicine, Emory University School of Medicine, Atlanta, GA (S.L.W.); Atlanta VA Center for Visual and Neurocognitive Rehabilitation, GA (S.L.W.); Department of Neurology, University of Iowa, Iowa City (H.P.A.); Extramural Research Program, National Institute of Neurological Disorders and Stroke, Bethesda, MD (D.C.); Department of Rehabilitation Medicine, MedStar National Rehabilitation Hospital, Georgetown University, Washington, DC (A.W.D.); Washington DC VA Medical Center (A.W.D.); Department of Rehabilitation Sciences, University of Cincinnati, OH (K.D.); Data Coordination Unit, Department of Public Health Sciences, Medical University of South Carolina, Charleston (C.E., Y.Y.P.); Department of Neurosurgery, University of Minnesota, Minneapolis (A.G.); Office of Clinical Research, National Institute of Neurological Disorders and Stroke, Bethesda, MD (S.J.); Department of Neurology and Neurological Sciences, Stanford Stroke Center, Stanford University School of Medicine, CA (M.G.L.); Stroke Division, Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY (R.M.L.); Department of Occupational Therapy, University of Utah, Salt Lake City (L.R.); Department of Physical Medicine and Rehabilitation, Northwestern Feinberg School of Medicine, Chicago, IL (E.R.); Department of Neurology, University of Texas, Houston (S.I.S.); Department of Neurology, University of Pittsburgh Medical School, PA (L.R.W.); Neuroradiology Section, Department of Radiology, Stanford Healthcare and School of Medicine, CA (M.W.); University of Cincinnati Gardner Neuroscience Institute (J.P.B.) and Department of Neurology and Rehabilitation Medicine (J.P.B.), University of Cincinnati, OH
| | - Scott Janis
- From the Departments of Neurology, Anatomy and Neurobiology (S.C.C.), and Physical Medicine and Rehabilitation (S.C.C.), and the Sue and Bill Gross Stem Cell Research Center (S.C.C.), University of California, Irvine; Division of Physical Therapy, Department of Rehabilitation Medicine, Emory University School of Medicine, Atlanta, GA (S.L.W.); Atlanta VA Center for Visual and Neurocognitive Rehabilitation, GA (S.L.W.); Department of Neurology, University of Iowa, Iowa City (H.P.A.); Extramural Research Program, National Institute of Neurological Disorders and Stroke, Bethesda, MD (D.C.); Department of Rehabilitation Medicine, MedStar National Rehabilitation Hospital, Georgetown University, Washington, DC (A.W.D.); Washington DC VA Medical Center (A.W.D.); Department of Rehabilitation Sciences, University of Cincinnati, OH (K.D.); Data Coordination Unit, Department of Public Health Sciences, Medical University of South Carolina, Charleston (C.E., Y.Y.P.); Department of Neurosurgery, University of Minnesota, Minneapolis (A.G.); Office of Clinical Research, National Institute of Neurological Disorders and Stroke, Bethesda, MD (S.J.); Department of Neurology and Neurological Sciences, Stanford Stroke Center, Stanford University School of Medicine, CA (M.G.L.); Stroke Division, Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY (R.M.L.); Department of Occupational Therapy, University of Utah, Salt Lake City (L.R.); Department of Physical Medicine and Rehabilitation, Northwestern Feinberg School of Medicine, Chicago, IL (E.R.); Department of Neurology, University of Texas, Houston (S.I.S.); Department of Neurology, University of Pittsburgh Medical School, PA (L.R.W.); Neuroradiology Section, Department of Radiology, Stanford Healthcare and School of Medicine, CA (M.W.); University of Cincinnati Gardner Neuroscience Institute (J.P.B.) and Department of Neurology and Rehabilitation Medicine (J.P.B.), University of Cincinnati, OH
| | - Maarten G Lansberg
- From the Departments of Neurology, Anatomy and Neurobiology (S.C.C.), and Physical Medicine and Rehabilitation (S.C.C.), and the Sue and Bill Gross Stem Cell Research Center (S.C.C.), University of California, Irvine; Division of Physical Therapy, Department of Rehabilitation Medicine, Emory University School of Medicine, Atlanta, GA (S.L.W.); Atlanta VA Center for Visual and Neurocognitive Rehabilitation, GA (S.L.W.); Department of Neurology, University of Iowa, Iowa City (H.P.A.); Extramural Research Program, National Institute of Neurological Disorders and Stroke, Bethesda, MD (D.C.); Department of Rehabilitation Medicine, MedStar National Rehabilitation Hospital, Georgetown University, Washington, DC (A.W.D.); Washington DC VA Medical Center (A.W.D.); Department of Rehabilitation Sciences, University of Cincinnati, OH (K.D.); Data Coordination Unit, Department of Public Health Sciences, Medical University of South Carolina, Charleston (C.E., Y.Y.P.); Department of Neurosurgery, University of Minnesota, Minneapolis (A.G.); Office of Clinical Research, National Institute of Neurological Disorders and Stroke, Bethesda, MD (S.J.); Department of Neurology and Neurological Sciences, Stanford Stroke Center, Stanford University School of Medicine, CA (M.G.L.); Stroke Division, Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY (R.M.L.); Department of Occupational Therapy, University of Utah, Salt Lake City (L.R.); Department of Physical Medicine and Rehabilitation, Northwestern Feinberg School of Medicine, Chicago, IL (E.R.); Department of Neurology, University of Texas, Houston (S.I.S.); Department of Neurology, University of Pittsburgh Medical School, PA (L.R.W.); Neuroradiology Section, Department of Radiology, Stanford Healthcare and School of Medicine, CA (M.W.); University of Cincinnati Gardner Neuroscience Institute (J.P.B.) and Department of Neurology and Rehabilitation Medicine (J.P.B.), University of Cincinnati, OH
| | - Ronald M Lazar
- From the Departments of Neurology, Anatomy and Neurobiology (S.C.C.), and Physical Medicine and Rehabilitation (S.C.C.), and the Sue and Bill Gross Stem Cell Research Center (S.C.C.), University of California, Irvine; Division of Physical Therapy, Department of Rehabilitation Medicine, Emory University School of Medicine, Atlanta, GA (S.L.W.); Atlanta VA Center for Visual and Neurocognitive Rehabilitation, GA (S.L.W.); Department of Neurology, University of Iowa, Iowa City (H.P.A.); Extramural Research Program, National Institute of Neurological Disorders and Stroke, Bethesda, MD (D.C.); Department of Rehabilitation Medicine, MedStar National Rehabilitation Hospital, Georgetown University, Washington, DC (A.W.D.); Washington DC VA Medical Center (A.W.D.); Department of Rehabilitation Sciences, University of Cincinnati, OH (K.D.); Data Coordination Unit, Department of Public Health Sciences, Medical University of South Carolina, Charleston (C.E., Y.Y.P.); Department of Neurosurgery, University of Minnesota, Minneapolis (A.G.); Office of Clinical Research, National Institute of Neurological Disorders and Stroke, Bethesda, MD (S.J.); Department of Neurology and Neurological Sciences, Stanford Stroke Center, Stanford University School of Medicine, CA (M.G.L.); Stroke Division, Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY (R.M.L.); Department of Occupational Therapy, University of Utah, Salt Lake City (L.R.); Department of Physical Medicine and Rehabilitation, Northwestern Feinberg School of Medicine, Chicago, IL (E.R.); Department of Neurology, University of Texas, Houston (S.I.S.); Department of Neurology, University of Pittsburgh Medical School, PA (L.R.W.); Neuroradiology Section, Department of Radiology, Stanford Healthcare and School of Medicine, CA (M.W.); University of Cincinnati Gardner Neuroscience Institute (J.P.B.) and Department of Neurology and Rehabilitation Medicine (J.P.B.), University of Cincinnati, OH
| | - Yuko Y Palesch
- From the Departments of Neurology, Anatomy and Neurobiology (S.C.C.), and Physical Medicine and Rehabilitation (S.C.C.), and the Sue and Bill Gross Stem Cell Research Center (S.C.C.), University of California, Irvine; Division of Physical Therapy, Department of Rehabilitation Medicine, Emory University School of Medicine, Atlanta, GA (S.L.W.); Atlanta VA Center for Visual and Neurocognitive Rehabilitation, GA (S.L.W.); Department of Neurology, University of Iowa, Iowa City (H.P.A.); Extramural Research Program, National Institute of Neurological Disorders and Stroke, Bethesda, MD (D.C.); Department of Rehabilitation Medicine, MedStar National Rehabilitation Hospital, Georgetown University, Washington, DC (A.W.D.); Washington DC VA Medical Center (A.W.D.); Department of Rehabilitation Sciences, University of Cincinnati, OH (K.D.); Data Coordination Unit, Department of Public Health Sciences, Medical University of South Carolina, Charleston (C.E., Y.Y.P.); Department of Neurosurgery, University of Minnesota, Minneapolis (A.G.); Office of Clinical Research, National Institute of Neurological Disorders and Stroke, Bethesda, MD (S.J.); Department of Neurology and Neurological Sciences, Stanford Stroke Center, Stanford University School of Medicine, CA (M.G.L.); Stroke Division, Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY (R.M.L.); Department of Occupational Therapy, University of Utah, Salt Lake City (L.R.); Department of Physical Medicine and Rehabilitation, Northwestern Feinberg School of Medicine, Chicago, IL (E.R.); Department of Neurology, University of Texas, Houston (S.I.S.); Department of Neurology, University of Pittsburgh Medical School, PA (L.R.W.); Neuroradiology Section, Department of Radiology, Stanford Healthcare and School of Medicine, CA (M.W.); University of Cincinnati Gardner Neuroscience Institute (J.P.B.) and Department of Neurology and Rehabilitation Medicine (J.P.B.), University of Cincinnati, OH
| | - Lorie Richards
- From the Departments of Neurology, Anatomy and Neurobiology (S.C.C.), and Physical Medicine and Rehabilitation (S.C.C.), and the Sue and Bill Gross Stem Cell Research Center (S.C.C.), University of California, Irvine; Division of Physical Therapy, Department of Rehabilitation Medicine, Emory University School of Medicine, Atlanta, GA (S.L.W.); Atlanta VA Center for Visual and Neurocognitive Rehabilitation, GA (S.L.W.); Department of Neurology, University of Iowa, Iowa City (H.P.A.); Extramural Research Program, National Institute of Neurological Disorders and Stroke, Bethesda, MD (D.C.); Department of Rehabilitation Medicine, MedStar National Rehabilitation Hospital, Georgetown University, Washington, DC (A.W.D.); Washington DC VA Medical Center (A.W.D.); Department of Rehabilitation Sciences, University of Cincinnati, OH (K.D.); Data Coordination Unit, Department of Public Health Sciences, Medical University of South Carolina, Charleston (C.E., Y.Y.P.); Department of Neurosurgery, University of Minnesota, Minneapolis (A.G.); Office of Clinical Research, National Institute of Neurological Disorders and Stroke, Bethesda, MD (S.J.); Department of Neurology and Neurological Sciences, Stanford Stroke Center, Stanford University School of Medicine, CA (M.G.L.); Stroke Division, Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY (R.M.L.); Department of Occupational Therapy, University of Utah, Salt Lake City (L.R.); Department of Physical Medicine and Rehabilitation, Northwestern Feinberg School of Medicine, Chicago, IL (E.R.); Department of Neurology, University of Texas, Houston (S.I.S.); Department of Neurology, University of Pittsburgh Medical School, PA (L.R.W.); Neuroradiology Section, Department of Radiology, Stanford Healthcare and School of Medicine, CA (M.W.); University of Cincinnati Gardner Neuroscience Institute (J.P.B.) and Department of Neurology and Rehabilitation Medicine (J.P.B.), University of Cincinnati, OH
| | - Elliot Roth
- From the Departments of Neurology, Anatomy and Neurobiology (S.C.C.), and Physical Medicine and Rehabilitation (S.C.C.), and the Sue and Bill Gross Stem Cell Research Center (S.C.C.), University of California, Irvine; Division of Physical Therapy, Department of Rehabilitation Medicine, Emory University School of Medicine, Atlanta, GA (S.L.W.); Atlanta VA Center for Visual and Neurocognitive Rehabilitation, GA (S.L.W.); Department of Neurology, University of Iowa, Iowa City (H.P.A.); Extramural Research Program, National Institute of Neurological Disorders and Stroke, Bethesda, MD (D.C.); Department of Rehabilitation Medicine, MedStar National Rehabilitation Hospital, Georgetown University, Washington, DC (A.W.D.); Washington DC VA Medical Center (A.W.D.); Department of Rehabilitation Sciences, University of Cincinnati, OH (K.D.); Data Coordination Unit, Department of Public Health Sciences, Medical University of South Carolina, Charleston (C.E., Y.Y.P.); Department of Neurosurgery, University of Minnesota, Minneapolis (A.G.); Office of Clinical Research, National Institute of Neurological Disorders and Stroke, Bethesda, MD (S.J.); Department of Neurology and Neurological Sciences, Stanford Stroke Center, Stanford University School of Medicine, CA (M.G.L.); Stroke Division, Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY (R.M.L.); Department of Occupational Therapy, University of Utah, Salt Lake City (L.R.); Department of Physical Medicine and Rehabilitation, Northwestern Feinberg School of Medicine, Chicago, IL (E.R.); Department of Neurology, University of Texas, Houston (S.I.S.); Department of Neurology, University of Pittsburgh Medical School, PA (L.R.W.); Neuroradiology Section, Department of Radiology, Stanford Healthcare and School of Medicine, CA (M.W.); University of Cincinnati Gardner Neuroscience Institute (J.P.B.) and Department of Neurology and Rehabilitation Medicine (J.P.B.), University of Cincinnati, OH
| | - Sean I Savitz
- From the Departments of Neurology, Anatomy and Neurobiology (S.C.C.), and Physical Medicine and Rehabilitation (S.C.C.), and the Sue and Bill Gross Stem Cell Research Center (S.C.C.), University of California, Irvine; Division of Physical Therapy, Department of Rehabilitation Medicine, Emory University School of Medicine, Atlanta, GA (S.L.W.); Atlanta VA Center for Visual and Neurocognitive Rehabilitation, GA (S.L.W.); Department of Neurology, University of Iowa, Iowa City (H.P.A.); Extramural Research Program, National Institute of Neurological Disorders and Stroke, Bethesda, MD (D.C.); Department of Rehabilitation Medicine, MedStar National Rehabilitation Hospital, Georgetown University, Washington, DC (A.W.D.); Washington DC VA Medical Center (A.W.D.); Department of Rehabilitation Sciences, University of Cincinnati, OH (K.D.); Data Coordination Unit, Department of Public Health Sciences, Medical University of South Carolina, Charleston (C.E., Y.Y.P.); Department of Neurosurgery, University of Minnesota, Minneapolis (A.G.); Office of Clinical Research, National Institute of Neurological Disorders and Stroke, Bethesda, MD (S.J.); Department of Neurology and Neurological Sciences, Stanford Stroke Center, Stanford University School of Medicine, CA (M.G.L.); Stroke Division, Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY (R.M.L.); Department of Occupational Therapy, University of Utah, Salt Lake City (L.R.); Department of Physical Medicine and Rehabilitation, Northwestern Feinberg School of Medicine, Chicago, IL (E.R.); Department of Neurology, University of Texas, Houston (S.I.S.); Department of Neurology, University of Pittsburgh Medical School, PA (L.R.W.); Neuroradiology Section, Department of Radiology, Stanford Healthcare and School of Medicine, CA (M.W.); University of Cincinnati Gardner Neuroscience Institute (J.P.B.) and Department of Neurology and Rehabilitation Medicine (J.P.B.), University of Cincinnati, OH
| | - Lawrence R Wechsler
- From the Departments of Neurology, Anatomy and Neurobiology (S.C.C.), and Physical Medicine and Rehabilitation (S.C.C.), and the Sue and Bill Gross Stem Cell Research Center (S.C.C.), University of California, Irvine; Division of Physical Therapy, Department of Rehabilitation Medicine, Emory University School of Medicine, Atlanta, GA (S.L.W.); Atlanta VA Center for Visual and Neurocognitive Rehabilitation, GA (S.L.W.); Department of Neurology, University of Iowa, Iowa City (H.P.A.); Extramural Research Program, National Institute of Neurological Disorders and Stroke, Bethesda, MD (D.C.); Department of Rehabilitation Medicine, MedStar National Rehabilitation Hospital, Georgetown University, Washington, DC (A.W.D.); Washington DC VA Medical Center (A.W.D.); Department of Rehabilitation Sciences, University of Cincinnati, OH (K.D.); Data Coordination Unit, Department of Public Health Sciences, Medical University of South Carolina, Charleston (C.E., Y.Y.P.); Department of Neurosurgery, University of Minnesota, Minneapolis (A.G.); Office of Clinical Research, National Institute of Neurological Disorders and Stroke, Bethesda, MD (S.J.); Department of Neurology and Neurological Sciences, Stanford Stroke Center, Stanford University School of Medicine, CA (M.G.L.); Stroke Division, Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY (R.M.L.); Department of Occupational Therapy, University of Utah, Salt Lake City (L.R.); Department of Physical Medicine and Rehabilitation, Northwestern Feinberg School of Medicine, Chicago, IL (E.R.); Department of Neurology, University of Texas, Houston (S.I.S.); Department of Neurology, University of Pittsburgh Medical School, PA (L.R.W.); Neuroradiology Section, Department of Radiology, Stanford Healthcare and School of Medicine, CA (M.W.); University of Cincinnati Gardner Neuroscience Institute (J.P.B.) and Department of Neurology and Rehabilitation Medicine (J.P.B.), University of Cincinnati, OH
| | - Max Wintermark
- From the Departments of Neurology, Anatomy and Neurobiology (S.C.C.), and Physical Medicine and Rehabilitation (S.C.C.), and the Sue and Bill Gross Stem Cell Research Center (S.C.C.), University of California, Irvine; Division of Physical Therapy, Department of Rehabilitation Medicine, Emory University School of Medicine, Atlanta, GA (S.L.W.); Atlanta VA Center for Visual and Neurocognitive Rehabilitation, GA (S.L.W.); Department of Neurology, University of Iowa, Iowa City (H.P.A.); Extramural Research Program, National Institute of Neurological Disorders and Stroke, Bethesda, MD (D.C.); Department of Rehabilitation Medicine, MedStar National Rehabilitation Hospital, Georgetown University, Washington, DC (A.W.D.); Washington DC VA Medical Center (A.W.D.); Department of Rehabilitation Sciences, University of Cincinnati, OH (K.D.); Data Coordination Unit, Department of Public Health Sciences, Medical University of South Carolina, Charleston (C.E., Y.Y.P.); Department of Neurosurgery, University of Minnesota, Minneapolis (A.G.); Office of Clinical Research, National Institute of Neurological Disorders and Stroke, Bethesda, MD (S.J.); Department of Neurology and Neurological Sciences, Stanford Stroke Center, Stanford University School of Medicine, CA (M.G.L.); Stroke Division, Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY (R.M.L.); Department of Occupational Therapy, University of Utah, Salt Lake City (L.R.); Department of Physical Medicine and Rehabilitation, Northwestern Feinberg School of Medicine, Chicago, IL (E.R.); Department of Neurology, University of Texas, Houston (S.I.S.); Department of Neurology, University of Pittsburgh Medical School, PA (L.R.W.); Neuroradiology Section, Department of Radiology, Stanford Healthcare and School of Medicine, CA (M.W.); University of Cincinnati Gardner Neuroscience Institute (J.P.B.) and Department of Neurology and Rehabilitation Medicine (J.P.B.), University of Cincinnati, OH
| | - Joseph P Broderick
- From the Departments of Neurology, Anatomy and Neurobiology (S.C.C.), and Physical Medicine and Rehabilitation (S.C.C.), and the Sue and Bill Gross Stem Cell Research Center (S.C.C.), University of California, Irvine; Division of Physical Therapy, Department of Rehabilitation Medicine, Emory University School of Medicine, Atlanta, GA (S.L.W.); Atlanta VA Center for Visual and Neurocognitive Rehabilitation, GA (S.L.W.); Department of Neurology, University of Iowa, Iowa City (H.P.A.); Extramural Research Program, National Institute of Neurological Disorders and Stroke, Bethesda, MD (D.C.); Department of Rehabilitation Medicine, MedStar National Rehabilitation Hospital, Georgetown University, Washington, DC (A.W.D.); Washington DC VA Medical Center (A.W.D.); Department of Rehabilitation Sciences, University of Cincinnati, OH (K.D.); Data Coordination Unit, Department of Public Health Sciences, Medical University of South Carolina, Charleston (C.E., Y.Y.P.); Department of Neurosurgery, University of Minnesota, Minneapolis (A.G.); Office of Clinical Research, National Institute of Neurological Disorders and Stroke, Bethesda, MD (S.J.); Department of Neurology and Neurological Sciences, Stanford Stroke Center, Stanford University School of Medicine, CA (M.G.L.); Stroke Division, Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY (R.M.L.); Department of Occupational Therapy, University of Utah, Salt Lake City (L.R.); Department of Physical Medicine and Rehabilitation, Northwestern Feinberg School of Medicine, Chicago, IL (E.R.); Department of Neurology, University of Texas, Houston (S.I.S.); Department of Neurology, University of Pittsburgh Medical School, PA (L.R.W.); Neuroradiology Section, Department of Radiology, Stanford Healthcare and School of Medicine, CA (M.W.); University of Cincinnati Gardner Neuroscience Institute (J.P.B.) and Department of Neurology and Rehabilitation Medicine (J.P.B.), University of Cincinnati, OH
| |
Collapse
|
30
|
Wortman-Jutt S, Edwards DJ. Transcranial Direct Current Stimulation in Poststroke Aphasia Recovery. Stroke 2017; 48:820-826. [PMID: 28174328 DOI: 10.1161/strokeaha.116.015626] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2016] [Revised: 11/17/2016] [Accepted: 12/15/2016] [Indexed: 11/16/2022]
Affiliation(s)
- Susan Wortman-Jutt
- From the Burke Rehabilitation Hospital, White Plains, NY (S.W.-J.); Neuromodulation and Human Motor Control Laboratory, Burke Medical Research Institute, White Plains, NY (D.J.E.); Department of Neurology, Weill-Cornell Medical College, New York, NY (D.J.E.); School of Medical and Health Sciences, Edith Cowan University, Western Australia (D.J.E.); and Beth-Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (D.J.E.).
| | - Dylan J Edwards
- From the Burke Rehabilitation Hospital, White Plains, NY (S.W.-J.); Neuromodulation and Human Motor Control Laboratory, Burke Medical Research Institute, White Plains, NY (D.J.E.); Department of Neurology, Weill-Cornell Medical College, New York, NY (D.J.E.); School of Medical and Health Sciences, Edith Cowan University, Western Australia (D.J.E.); and Beth-Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (D.J.E.)
| |
Collapse
|
31
|
Mechanisms, Imaging, and Therapy in Stroke Recovery. Transl Stroke Res 2016; 8:1-2. [PMID: 27714670 DOI: 10.1007/s12975-016-0503-5] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2016] [Accepted: 09/27/2016] [Indexed: 12/19/2022]
|
32
|
The pros and cons of intravenous thrombolysis in stroke. Lancet Neurol 2016; 15:997-8. [DOI: 10.1016/s1474-4422(16)30159-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2016] [Accepted: 06/29/2016] [Indexed: 11/19/2022]
|
33
|
Neuro-protective Mechanisms of Lycium barbarum. Neuromolecular Med 2016; 18:253-63. [PMID: 27033360 DOI: 10.1007/s12017-016-8393-y] [Citation(s) in RCA: 35] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2016] [Accepted: 03/21/2016] [Indexed: 02/07/2023]
Abstract
Neuronal diseases, including retinal disorders, stroke, Alzheimer's disease, Parkinson's disease and spinal cord injury, affect a large number of people worldwide and cause heavy social and economic burdens. Although many efforts have been made by scientists and clinicians to develop novel drug and healthcare strategies, few of them received satisfactory outcomes to date. Lycium barbarum is a traditional homology of medicine and food in Chinese medicine, with the capability to nourish the eyes, liver and kidneys. Recent studies have also explored its powerful neuro-protective effects on a number of neuronal diseases. In the current review, we collected key recent findings regarding the neuro-protective effects and mechanisms of L. barbarum derivatives, primarily its polysaccharide (LBP) , in some common diseases of the nervous system. A comprehensive comparison with currently available drugs has also been discussed. In general, LBP is a promising neuronal protector with potent ameliorative effects on key pathological events, such as oxidative stress, inflammation, apoptosis and cell death with minimal side effects.
Collapse
|